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ABSTRACT 
Non-thermal Dielectric Barrier Discharge (DBD) Treated Phosphate Buffer Saline (PBS): 
Mechanisms of Bacterial Inactivation and Cellular Toxicity 
Adam D. Yost 
Advisors: Suresh G. Joshi, MD, PhD 
 
 
The recent results by our group have shown that non-thermal dielectric-barrier 
discharge plasma (DBD) -activated liquids acquire strong antimicrobial properties and 
have the potential to control bacterial pathogens. However, the underlying bacterial cell 
responses to these activated liquids are yet to be fully understood. In this study, we 
demonstrated that plasma-activated phosphate-buffered saline (PBS) solution induced 
severe oxidative stress in Escherichia coli cells, and that this solution generated strong 
oxidants.  We further explored the free radical species and chemical products generated 
in this solution that lead to stable topical disinfectant.  This novel antibacterial solution 
has been studied in vitro and in vivo for cellular toxicity, demonstrating potential as a 
wound disinfectant. 
Analysis further showed that the reactive oxygen species (ROS) scavengers, α-
tocopherol and catalase, were able to protect and rescue E. coli from cell death. The 
transcription factors, oxyR and soxRS were activated in E. coli cells during exposure to 
this antimicrobial solution. Results indicated that the management of this oxidative stress 
was regulated by oxyR and soxyRS regulons and mediated predominantly through the 
gene transcription of katG and sodA (up-regulated) that deactivate the generated oxidants. 
The inactivation involved loss of E. coli membrane potential and membrane integrity, 
xvi 
 
lipid peroxidation, accumulation of 8-hydroxy-deoxyguinosine (8OHdG), and severe 
DNA damage. 
 In parallel experiments, the species contained in this novel solution were analyzed 
using electron spin resonance and ultraviolet-visible spectroscopy.  Reactive oxygen 
species (hydroxyl radicals, superoxide, and singlet oxygen) and reactive nitrogen species 
(nitric oxide, nitrate, and nitrite) were detected and work synergistically to create a robust 
antimicrobial agent.  Application of this plasma-activated solution on animal models 
provided minimal injury site toxicity while reducing the infected wound by > 3 logs. 
 This study provides a greater understand of the mechanism of bacterial 
inactivation, the pathways activated when exposed to plasma-activated PBS, the specific 
species generated and contained within the solution, and its potential as a topical wound 
disinfectant.  Thus contributions to the fields of plasma disinfection, plasma medicine, 
and infection control were made. 
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1. CHAPTER I:  INTRODUCTION AND LITERARY REVIEW 
 
1.1. Introduction 
Pathogens in their planktonic form contaminate inanimate and animate surfaces, 
form biofilms, and thus act as a disseminating source of infection.  A recent report 
demonstrates that the powerful biocides used in hospitals are unable to decontaminate 
efficiently and about 3% to 80% of pathogens survive in biofilms [1].  Effective 
disinfection is required to limit these reservoirs of multi-drug resistant (MDR) pathogens, 
and new technology is needed to achieve this goal.  We recently demonstrated that 
pathogens, including Escherichia coli, are rapidly inactivated by direct non-thermal 
dielectric barrier discharge (DBD) plasma, both in their planktonic and biofilm forms [2-
4]  in 180 and 300 seconds, respectively, and making this technique ideal for disinfection.  
In parallel, we have determined that E. coli inactivation induced by direct plasma 
bombardment involves membrane-lipid peroxidation and oxidative DNA damage 
mediated by the generation of reactive oxygen species (ROS) [5].  For the first time, we 
demonstrated that non-thermal plasma can be used to generate antimicrobial solutions, 
and that these solutions have a broad spectrum activity against multi-drug resistant 
pathogenic bacteria [6]. 
1.2. Antiseptics, Disinfectants and Sterilization 
There are three common ways to inactivate bacteria: antisepsis, disinfection, and 
sterilization.  Inactivation by the three processes is based on the method of application 
and the variable amount of microbial decontamination.  Antiseptics prevent the growth of 
disease causing microorganisms in or on living tissue.  Disinfectants eliminate most 
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microorganisms on inanimate objects or surfaces.  All of these techniques are essential 
parts of infection control and help prevent nosocomial infections [7].  However, neither is 
responsible for 100% decontamination.  Sterilization is the process that eliminates all 
forms of life on inanimate objects and surfaces, including spores. 
1.2.1. Antiseptics 
Ignaz Semmelweiss was responsible for the first usage of antiseptics during the 
mid-1800s.  When doctors and nurses washed their hands with chloride of lime solution 
before and after surgery, hospital acquired infection rates dropped [8].  Antiseptics are 
primarily used to lower the levels of microorganism on living tissue and often used 
topically to reduce the risk of infection.  Common uses include hand washing, pre-
operative skin disinfection, mucous membrane disinfection, infection prevention of 
wounds and burns, and treatment of mouth and throat infections [9-13].  Ideal antiseptics 
possess the following qualities: 
• Broad spectrum activity 
• Low irritancy 
• Low allergenicity 
• Good tolerance 
• No (or low) cytotoxicity 
• Fast and long-lasting efficacy 
• No (or limited) inhibition by organic matter 
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• No propensity to select bacterial resistance [14] 
Antiseptics produce a high percentage of decontamination usually without irritating the 
tissue.  Factors involved in irritancy include method of application, concentration of 
antiseptic, repeated applications to an area, and site of the application [14].  Antiseptics 
can also be used as disinfectants depending on the concentration of the active agent and 
the microorganism of interest [15].  A comprehensive list of antiseptics is given in Table 
1. 
 
Table 1: List of Antiseptics [16] 
Type Agent 
 
Alcohols Ethyl alcohol 70% 
Isopropyl alcohol 70% 
Chlorhexidine Chlorhexidine gluconate 
Chlorhexidine acetate 
Antibacterial dyes Proflavin hemisulphate 
Triphenylmethane 
Gentian violet 
Peroxides and Permanganates Hydrogen Peroxide 
Potassium permanganate 
Benzoyl peroxide 
Halogenated phenol derivatives Chlorocresol 
Chloroxylenol 
Chlorophene 
Hexachlorophane 
Quinolone derivatives Hydroxyquinoline sulphate 
Potassium hydroxyquinoline sulphate 
Chlorquinadol 
Dequalinium chloride 
Quaternary ammonium compounds Benzalkonium chloride 
Benzethonium chloride 
Cetrimide 
Dofanium chloride 
Domiphen bromide 
Methylbenzethonium chloride 
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1.2.2. Disinfectants 
Disinfectants, similar to antiseptics, are chemical or biological products used on 
inanimate objects and surfaces.  Since there is no concern for direct systemic cytotoxic 
effects, the concentrations of these disinfectants tend to be stronger in comparison to 
antiseptics.  While they are extremely bactericidal, they are more likely to be sporostatic 
than sporicidal [15].   
 
Table 2: Action and Activity of Chemical Disinfectants [17] 
Type Method of Action Antimicrobial 
Activity 
Use 
Alcohol Denaturing of proteins Bactericidal 
Virucidal 
Fungicidal 
Thermometers 
Scissors 
Stethoscopes 
External Surfaces 
Chlorine Compounds Oxidation 
Amino acid chlorination 
Inhibit protein synthesis 
Decreased ATP 
DNA breaks 
Bactericidal 
Virucidal 
Fungicidal 
Sporostatic 
Blood spills 
Countertops and Floors 
Water treatment 
Spills of body fluid 
Formaldehyde Alkylating proteins and ring 
nitrogen atoms of purines 
Bactericidal 
Virucidal 
Fungicidal 
Sporicidal 
Prepare viral vaccines 
Embalming agent 
Preserve specimens 
Fumigation 
Glutaraldehyde Alkylating sulfhydryl, 
hydroxyl, carboxyl, and 
amino groups 
Bactericidal 
Virucidal 
Fungicidal 
Sporocidal 
Endoscopes 
Dialyzers 
Transducers 
Respiratory equipment 
Hydrogen Peroxide Hydroxyl free radicals Bactericidal 
Virucidal 
Fungicidal 
Sporocidal 
Surfaces 
Contact lenses 
Ventilators 
Fabrics 
Endoscopes 
Iodophors Penetrates cell wall 
Disruption of protein and 
nucleic acid structure and 
synthesis 
Bactericidal 
Virucidal 
Fungistatic 
Sporostatic 
Hydrotherapy Tanks 
Thermometers 
Endoscopes 
Ortho-phthalaldehyde 
(OPA) 
Denaturing of proteins and 
amino acids 
Bactericidal 
Virucidal 
Sporostatic 
 
Endoscopes 
Respiratory equipment 
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Peracetic Acid Denaturing of proteins 
Disrupts cell wall 
permeability 
Bactericidal 
Virucidal 
Fungicidal 
Sporostatic 
Medical, surgical, and 
dental instruments 
Phenolics Protoplasmic poison 
Cell wall leakage 
Bactericidal 
Virustatic 
Fungicidal 
Environmental surfaces 
Noncritical medical 
devices 
Quaternary Ammonium 
Compounds 
Inactivation of enzymes 
Denaturing of proteins 
Disrupts cell membrane 
Bactericidal 
Virustatic 
Fungicidal 
Environmental surfaces 
Noncritical medical 
equipment 
 
A comprehensive list of chemical disinfectants is given in Table 2.  Ethanol, 
isopropanol, and n-propanol are the most widely used alcohols for disinfection [18].  
While some alcohols can inhibit sporulation, they lack sporicidal activity and therefore 
cannot be used in sterilization techniques [19].  Sodium hypochlorite, chlorine dioxide, 
and sodium dichloroisocyanurate are the three most important types of chlorine-releasing 
agents [15].  They have been shown to inhibit bacterial DNA and protein synthesis as 
well as membrane degradation [20-22].  Chlorine-releasing agents also demonstrate 
virucidal activity [23, 24] and even sporicidal properties at very high concentrations [25].  
Formaldehyde, glutaraldehyde, and ortho-phthalaldehyde (OPA) are the most common 
aldehydes used in disinfection.  Formaldehyde is an effective bactericidal, virucidal, and 
sporicidal water soluble gas [15], but has been known to work slower than glutaraldehyde 
[26].  OPA is the most recent aldehyde to be used as a disinfectant and has been 
suggested as a replacement to glutaraldhyde usage [27].  While it is a less potent cross-
linking agent, it is easily uptaken through microorganism outer membranes via its 
lipophilic aromatic structure [28].   Disinfectant peroxides include hydrogen peroxide and 
peracetic acid.  Hydrogen peroxide, both in liquid and gas phase, is a well-known 
disinfectant of bacteria, viruses, and fungus.  It is environmentally friendly, as it degrades 
to water and oxygen over a short period of time.  While microorganisms have internal 
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machinery to protect against the oxidative stress produced by hydrogen peroxide, varying 
the concentration of the disinfectant is enough to overwhelm the biological defense 
system.    Liquid H2O2 is commercially available in concentration ranges from 3 – 90% 
[15].  At high concentrations and extended exposure times, hydrogen peroxide can 
produce sporicidal results.  Peracetic acid is more efficient disinfectant peroxide than 
hydrogen peroxide, as it requires a lower active concentration to generate bactericidal, 
virucidal, fungicidal and sporicidal activity [29, 30].  Iodophors are soluble iodine-
releasing agents which act as a reservoir of active iodine.  They are a safer alternative to 
iodine as the corrosive side effect on surfaces and irritation of skin is greatly diminished 
[31].  However, they are less effective against fungus and spores [7].  Phenolic 
antimicrobials are considered protoplasmic poisons and disinfects via cell wall leakage.   
Triclosan and Hexachlorophene are two bis-phenols, hydroxyl-halogenated derivatives of 
two phenolic groups [32].  Quaternary Ammonium Compounds (QACs) can be used as 
both antiseptics and disinfectants.  They inactivate through membrane penetration, cell 
wall leakage, and autolytic lysing [33].  Phenols and QACs are generally used on 
environmental surfaces and non-critical medical equipment [17].  Some of these 
disinfectants have become a common source of occupational and patient irritation [14, 
17] and must be carefully selected depending on the inanimate object or surface that 
requires disinfection. 
Physical disinfection is an alternative to chemical disinfection.  Nonionizing 
radiation (ionizing, ultra-violet radiation) and moist heat are the most popular methods of 
physical disinfection.  Ionizing radiation is the process of stripping electrons from the 
atoms of the material in which it interacts [34].  Types of ionizing radiation include x-
7 
 
rays, γ-rays, high-speed electrons, protons, and α-rays.  Single and double strain DNA 
breaks occur in microorganisms following ionizing radiation [35].  Ultra-violet (UV) 
radiation does not strip an electron from an atom but rather excite the atom.  Maximum 
bactericidal activity of UV radiation occurs at 260 nm [34, 36].  Moist heat disinfection 
requires a threshold of application of temperature and exposure time in order to safely 
and efficiently disinfect inanimate objects [37].   Heat sensitive equipment and liquids 
can be critically damaged if temperature and exposure time exceed the material safety 
properties. 
1.2.3. Sterilization 
Implanted medical devices and surgical instruments that come in contact with 
sterile body tissue or fluid are considered critical items [17].     Due to the operational 
nature of these devices, they must be sterile in nature before usage as to prevent disease 
transmission.  Sterilization is a validated process that ensures completely freeing of 
microbial life [15].  A comprehensive list of chemical disinfectants is given in Table 3. 
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Table 3: Action and Activity of Sterilization Agents [17] 
Types Method of Action Antimicrobial 
Activity 
Use 
Steam Irreversible coagulation and 
denaturation of enzymes and 
proteins 
Microbiocidal 
Sporicidal 
Critical items 
Semi items 
Microbio waste 
Sharps containers  
Flash Irreversible coagulation and 
denaturation of enzymes and 
proteins 
Microbiocidal 
Sporicidal 
Patient-care items that 
cannot be packaged or 
stored before use 
Dry-Heat Oxidation of cell constituents Microbiocidal 
Sporicidal 
Powders 
Petroleum products 
Sharp instruments 
Ionizing Radiation DNA degradation 
Intracellular radicals 
Microbiocidal 
Sporicidal 
Transplant tissue 
Pharmaceuticals 
Medical devices 
Formaldehyde Gas Alkylation of protein, DNA 
and RNA 
Microbiocidal 
Sporicidal 
Critical items that are 
heat sensitive 
Ethylene Oxide Alkylation of protein, DNA 
and RNA 
Microbiocidal 
Sporicidal 
Critical items that are 
moisture or heat 
sensitive 
H2O2 Gas Plasma Generation of hydroxyl and 
hydroproxyl free radicals 
Microbiocidal 
Sporicidal 
Critical items that are 
moisture or heat 
sensitive 
Peracetic Acid Denature proteins 
Disrupts cell wall 
permeability 
Microbiocidal 
Sporicidal 
Medical and surgical 
equipment 
 
 Saturated steam under pressure is the most common and dependable form of 
sterilization.  Large sterilization units called autoclaves exposed medical items, liquids, 
and waste to direct steam contact at specific temperatures and pressures for a 
predetermined time.  Standard autoclave sterilization protocol is performed at 121oC and 
15 psi for at least 15 minutes.  While this method is inexpensive, rapid, and nontoxic it 
can also lead to corrosion of metal instruments [38-40].  Flash sterilization is a type of 
steam sterilization that occurs rapidly and for uncovered/unwrapped items.  The items are 
placed in an open tray allowing the steam to quickly penetrate and generate rapid 
sterilization.  Since the items are uncovered and are therefore exposed to microorganisms 
once removed from the autoclave, healthcare facilities have placed the units closer to 
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operating rooms and extended exposure times [17, 41].  Dry-heat sterilization is a safe 
alternative to moist heat sensitive items.  While it is nontoxic, environmentally safe, and 
noncorrosive, it is much slower and unsuitable for most heat sensitive materials [17, 42].   
 Ionizing radiation has been used to sterilize transplant tissue, prosthesis, 
pharmaceuticals, and medical devices.  Radiation can penetrate microorganisms and 
cause irreversible DNA damage.  However, it is more costly than other sterilization 
techniques and can have harmful effects on healthcare providers and patients [17].  
Formaldehyde steam is a low-temperature technique currently used in Europe.  Formalin 
is converted into formaldehyde steam and pumped into a sterilization chamber.  While 
the cycle time of formaldehyde sterilization is faster and cost of operation low, it operates 
at a relatively high temperature for a low-temperature technique and does not penetrate as 
well as similar chemical methods [17].  Ethylene oxide (ETO) is similar to steam 
sterilization as it requires varying temperature, moisture, and exposure time to safely and 
effectively sterilize critical medical equipment.  One extra parameter is the concentration 
of ETO gas injected into the sterilization chamber [43, 44].  ETO sterilization is able to 
penetrate better than most sterilization methods and is optimal for heat sensitive devices 
with long lumens.  Ethylene oxide is considerably costly, requires extended cycle times, 
inflammable, and is incredibly harmful to humans.  Exposure to the gas can cause 
irritation of the eyes and throat and has been linked to numerous neurological 
dysfunctions [43, 45]. Hydrogen peroxide gas plasma sterilizers utilize non-thermal 
plasma discharge to generate free radicals and ions in order to sterilize microorganisms.  
H2O2 gas is injected into the vacuum chamber along with the medical instruments.  A 
radio frequency or microwave power supply provides an electric field capable of causing 
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gas ionization within the chamber and producing plasma.  The process avoids extreme 
temperatures, has a short cycle time, and is compatible with 95% of medical devices [46].  
Peracetic acid sterilization is predominately used to sterilize various types of endoscopes.  
It is mixed with a sterilant and anticorrosive agent in a single dose container [17].  As for 
most sterilizing agents, peracetic acid is only effective if it comes in contact with the 
entire inner lumen of the scope.  If the wrong connector is used to connect the dosage 
container to the scope, sterilization is unlikely and a risk of infection is probable upon use 
[47]. 
1.3. Plasma 
Plasma, first defined by Irving Langmuir in the 1960s, is the fourth state of matter 
[48] (Fig. 1).  A discharge is produced when the surrounding gas is ionized.  Plasma can 
be a product of thermal ionization, i.e. – the sun, when extreme temperatures and rapid 
molecule movement can cause step-wise ionization.  Electrical plasma is created from 
ionization of gas by electric field.  It takes 1 electron volt (ev) to successful remove an 
electron from an atom/molecule in the surrounding gas.  This starts an electron avalanche 
cascade, with each free electron colliding with another atom, continuously freeing more 
electrons.  Plasma can be classified as thermal or non-thermal, depending on the 
temperature of the gas and electrons.  Thermal plasma is generated when the surrounding 
gas is in thermal equilibrium with the free electrons.  The energy transfer between the 
free electrons and the uncharged particles in the surrounding gas equals the energy 
transfer between the uncharged particles and the environment (Te = Tg).  In non-thermal 
plasma, these uncharged particles cool faster than the electron energy transfer to the 
environment (Te >> Tg) [2].  This non-equilibrium discharge produces “cold plasma” in 
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which the surrounding gas is cool to the touch.  Utilizing the surrounding air or applied 
gases such as helium, nitrogen and argon, it can also be conducted at atmospheric 
pressure.   
 
 
 
1.3.1. Thermal Plasma 
 Thermal plasma discharged has been widely studied and has been used 
extensively in industrial production, including processes such as etching, coating, metal 
cutting, welding, metallurgy, volatile organic compound (VOC) control, and combustion 
[49] (Fig. 2).   
 
 
Figure 1: The 4 states of matter 
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Figure 2: Thermal plasma processing applications [49] 
 
 
1.3.1.1. Devices and Applications 
Thermal plasma has been used as a cutting/welding alternative to lasers and 
electron beams.  The most common tool used for this type of cutting/welding is the 
plasma torch.  A gas (air, nitrogen, argon, oxygen) is passed through a small opening 
(nozzle) at high speeds.  An electric arc passing through the gas creates thermal 
equilibrium and elevates the temperature to the point of plasma generation [50-52].   
Plasma transferred wire arc has been used to coat materials and polymers with 
different metals.  Plasma is generated between a cathode and the desired coating metal 
wire.  During breakdown the wire is continuously feed through the discharge as it is 
consumed, creating constant plasma.  Compressed air is blown through the discharge 
area, propelling the now liquefied drops of metal onto the material being treated [53, 54].  
The droplets hit the surface, spread, and harden as they cool.  This method of coating is 
primarily used in the automotive industry on engine parts [55]. 
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Similar to transferred wire arc, plasma chemical vapor deposition (CVD) is used 
to create a thin film on the surface of a material [56].  Generally this technique is used in 
semiconductor manufacturing, particularly silicon dioxide, silicon carbide, and silicon 
nitride coating [57].  It is the favorite method of material disposition due to its uniform 
distribution and film quality.  Radio-frequency (RF) or alternating current (AC) is applied 
between two electrodes in a closed chamber.  While this process can be run at 
atmospheric pressure it is generally run at a few millitorrs [58-60]. 
  Thermal plasma has also been used in waste treatment.  Waste is broken down 
into usable by-products (combustible gas and inert slag) via extremely high temperatures 
generated by thermal plasma in an oxygen-starved environment [61].  Waste treatment by 
thermal plasma is environmentally preferred, as levels of air emission and slag toxicity 
are much lower than other thermal technologies [62, 63]. 
1.3.2. Non-Thermal Plasma 
 As previously stated, non-thermal plasma discharge occurs when ionized gas is 
created in non-equilibrium.  There are two classes of non-thermal discharge:  direct and 
indirect.  During direct discharge the surface of treatment acts as the grounding electrode.  
Therefore, microfilament formation occurs directly on the surface of the material of 
interest.  In indirect treatment the plasma is generated between two electrodes with the 
plasma products being transported to the surface of interested.  This is commonly done 
by created an airflow through the discharge (plasma afterglow) aimed toward the desired 
treatment surface.  Corona, gliding arc, and dielectric barrier discharge (DBD) are a few 
examples of direct treatment while plasma jet, plasma pencil, and pin-to-hole spark 
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discharge are examples of indirect treatment.  Our research explores DBD discharge as an 
effective antimicrobial agent and will be discussed later in the chapter. 
1.3.2.1. Devices and Applications 
 Corona discharge has been extensively used to treat materials in order to alter 
surface wettability and improve surface adhesion.  The discharge occurs once the electric 
field is strong enough to cause ionization in a gas or liquid.  As the electric field weakens 
when the distance between the electrode and the charged ions increase, streamer 
formation stops.  However, the ions still continue to travel away from the electrode and 
onto the opposing surface.  Corona discharge occurs at sharp corners, edges, points, and 
on small diameter wires.  These are the points of the electrode that produce the highest 
potential gradients.  Corona discharge has also been used to ionize air [64, 65], remove 
VOCs [66, 67], and produce ozone [68-70]. 
 Gliding arc discharge is unique in the case that it is both a thermal and non-
thermal discharge.  The gliding arc discharge starts at the shortest distance between the 
two electrodes (1-2 mm) and maintains thermal equilibrium.  Gas is then injected from 
the bottom of the discharge at a rate of 10m/s, causing the reaction to climb along the 
electrodes while the distance between the discharge slowing increases.  Eventually, the 
amount of heat loss surpasses the amount of applied voltage, and transition into non-
equilibrium phase occurs [71].  Once the non-thermal discharge dissipates, breakdown 
reoccurs at the initial location and the process repeats.  Gliding arc can be used in VOC 
removal [72] incineration of sulfur compounds [73], CO2 conversion [74], and 
decontamination and environmental control [75-77]. 
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 Non-thermal plasma jet is one example of indirect plasma.  Using a radio 
frequency (RF) or direct current (DC) power supply, non-thermal plasma is created 
between two electrodes.  Typically, the design is of a cylindrical nature with the inside of 
the cylinder acting as one electrode covered in a dielectric material and a metal wire in 
the center acting as the ground electrode.  Once breakdown is achieved, gas (such as air, 
oxygen, argon, helium, nitrogen, etc) is passed through the discharge at various flow 
rates.  The “plasma afterglow” is blown from the initial breakdown location and projected 
onto an adjacent object or surface.   
 Plasma pencil was designed as an alternative to the original plasma jet.  Within a 
cylindrical dielectric tube, two electrodes are placed with 1 cm from each other.  Each 
electrode consists of a perforated alumina disk surrounded by a copper ring.  The ring is 
large enough to partially cover the hole in the middle of the aluminum disk.  Helium or 
argon is then blown through the discharge and a plasma plume is created.  While this 
sounds very similar to the plasma jet, the creators of the plasma pencil utilized a pulsed 
power supply and determined that the plasma plume was not a constant stream of plasma 
afterglow but rather small plasma “bullets” traveling at very high speeds [78]. 
 Pin-to-hole (PHD) spark discharge has a similar configuration to jet plasmas.  In a 
polyethylene housing, a needle-like electrode runs down the center surrounded by a 
dielectric.  However, the very tip of this electrode is left exposed.  At the tip of the 
housing is a metal cap with a centralized hole that serves as the grounding electrode.  
During breakdown, there is both a thermal and non-thermal plasma discharge.  Air is 
forced through the housing, transferring both thermal and non-thermal products out of the 
centralized hole and towards the treatment zone.  Since this discharge runs at very low 
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current and low voltage while pulsed in microseconds, the air is able to cool the plasma 
making the emitted products room temperature [79].  Non-thermal plasma jet, plasma 
pencil, and PHD spark discharge are primarily used in the field of plasma medicine.  
Their individual contributions to the field will be expressed later in the chapter. 
1.3.2.2. Non-Thermal Dielectric Barrier Discharge (DBD) Plasma 
 The work done in our laboratory was completed with non-thermal dielectric 
barrier discharge (DBD) plasma.  DBD was first introduced in 1857 by Werner von 
Siemens as a method of ozone production [80].  Discharge occurs between two 
electrodes:  one high voltage and one ground (Fig. 3).  Passing an electric current 
between two metal electrodes produces a thermal spark.  In DBD plasma, the high 
voltage electrode is insulated with a dielectric material preventing spark discharge.  
Dielectrics polarize in an electric field, preventing the passing of electrons.  Glass and 
quartz are two common dielectrics used in manufacturing DBD electrodes. 
 
 
Figure 3: Diagram of a free floating dielectric barrier discharge electrode 
 
17 
 
 When the electric field is applied between the insulated high voltage electrode and 
the grounding electrode, ionization leads to an electron avalanche cascade.  One free 
electron is accelerated into a surround atom, knocking loose another electron.  This 
process continues, having more and more free electrons after each collision.   This 
process was first discovered by John Sealy Townsend in the early 1900s and is known as 
the Townsend discharge [81].  Within nanoseconds, there is an avalanche to streamer 
transition and a small channel of ionized plasma builds.  The electric field collapses with 
the buildup of electrons on the dielectric material, but leaves behind vibrational and 
electronic excitement in the streamer channel.  This is called microdischarge remnancy 
[82].   Since DBD utilizes pulsed microsecond alternating current (AC), the properties of 
the anode and cathode rapidly alternate.  This sends the building up of electrons back 
towards the grounding electrode, recreating the microfilaments (Fig. 4) 
 
 
Figure 4: Microdischarge initiation stages [82] 
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Uniform discharge occurs when the microfilaments evenly discharge on the entirety of 
the electrode surface.  Due to microdischarge remnant, charges left on the surface of the 
electrode do not have time to dissipate before the formation of the next microfilament.  
This causes the streamers to reform and strike the electrode surface at the same location 
continuously.  This is called the memory effect. 
1.3.3. Plasma Chemistry 
 Non-thermal DBD plasma begins with the ionization of air at atmospheric 
pressure.  Due to the ionization, the oxygen (O2) and nitrogen (N2) found in the air 
undergo bond breakage and are elevated to a higher state of excitation.  Two types of 
bond breakage occur during plasma discharge at atmospheric conditions:  heterolytic and 
homolytic.  Heterolytic reactions involve the movement of electron pairs between atoms 
while homolytic reactions involve the movement of a single electron [83] (Fig.5). 
 
 
Figure 5: Heterolytic (A) and homolytic (B) cleavage of oxygen 
 
These products lead to the formation of reactive oxygen species (ROS) and 
reactive nitrogen species (RNS).  Plasma produced ROS include ozone (O3), hydrogen 
peroxide (H2O2), hydroxyl radicals (OH•), superoxide (O2-), and singlet oxygen (O2(1Δg)), 
while the generated RNS include nitric oxide (NO), nitrite (NO2-), nitrate (NO3-), and 
peroxynitrite (ONOO-) [6, 84-86].  A comprehensive list of reaction products in 
atmospheric conditions can be found in Table 4. 
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Table 4: Product reactions in atmospheric conditions [83, 87-90] 
Chemical Product Chemical Reactions 
Oxygen and Nitrogen 
Atoms 
e- + O2  O• + O• + e- 
Ozone M + O + O2  O3• 
O3• + M  O3 + M 
Superoxide e- + O2  O2- 
Hydroxyl Radical H2O  H+ + OH- 
e- + H2O  H• + OH• 
Peroxyl Radical H• + O2 + M  HO2• + M 
OH• + H2O2  HO2• + H2O 
OH• + O3  HO2• + O2 
Hydrogen Peroxide OH• + OH•  H2O2 
HO2• + HO2•  H2O2 + O2 
Nitric Oxide N2 + O2  2 NO• 
N2 + O•  NO• + N• 
N• + O2  NO• + O• 
N• + O•  NO• 
Nitrite and Nitrate 3 NO2 + H2O  2 H+ + 2 NO3- + NO 
Peroxynitrous acid NO• + HO2  ONOOH 
NO2 + OH•  ONOOH 
Peroxynitrite ONOOH  ONOO- + H+ 
NO + O2-  ONOO- 
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All plasma products are generated during discharge in air.  Other laboratories 
have started directly plasma treating water, liquids and other buffers.  These chemically 
species have been shown to diffuse from gas phase and into the liquid medium [91-94].  
When these liquids are exposed to non-thermal plasma, pH measurements become very 
acidic.  It has been documented that the steady state pH of a plasma treated liquid is about 
2.8 [95-97].  This is usually due to the short lived nitrous, peroxynitrous acids, or the 
stable nitric acid [86, 93].  However, the presence of superoxide and formation of 
hydrogen peroxide enhance the solutions effects and further oxidize the short lived acids 
into the more stable nitric acid, perhaps creating a synergistic relationship between the 
generated RNS and ROS [96]. 
1.3.4. Plasma Medicine 
 The application of non-thermal plasma on biological systems and in medical 
procedures has become increasingly promising and has come to be known as plasma 
medicine.   Recently, non-thermal plasma has been explored as a therapeutic agent, 
wherein processes like modifying biological materials, removal of bacteria and 
decontaminating surfaces are involved. 
1.3.4.1. Plasma Accelerated Blood Coagulation 
 For decades thermal plasmas have been used to treat living tissue to stop wound 
bleeding by cauterization [90, 98, 99].  Non-thermal plasma has demonstrated the ability 
to coagulate blood at room temperature, avoiding the use of excessive head and thus 
preventing the damage of the surround tissues [100, 101].  A drop of blood left to 
coagulate unabated took 15 minutes while an identical drop from the same donor 
coagulated in under 1 minute following 15 seconds of DBD plasma treatment [100].  To 
21 
 
prove that this was an effect of direct non-thermal plasma and not due to potential 
increases in temperature, the blood droplet was covered in aluminum foil prior to DBD 
treatment.  The covered drop failed to coagulate immediately while the uncovered droplet 
exhibited a rapid clot layer [101] (Fig. 6). 
 
 
Figure 6: (a) and (b) Uncovered blood droplet pre- and post- DBD plasma treatment. (c) and (d) Covered 
blood droplet pre- and post- DBD plasma treatment [101] 
 
The process of natural blood coagulation is a complex process, involving multiple 
factors, and has been extensively studied [102].  The belief is that blood treated with 
DBD plasma changes the concentration of calcium by altering overall pH causing a redox 
reaction while simultaneously causing rapid fibrinogen aggregation [100, 101].  Another 
group reported similar results with atmospheric pressure plasma jet (APPJ), coagulated in 
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vitro blood samples in 20 seconds and in vivo samples in 1 minute [103].  They attributed 
this phenomenon to the large formation of NO radicals during plasma treatment.  
1.3.4.2. Plasma Applications in Wound Healing and Dermatology 
 Non-thermal plasma has been used topically in superficial wound healing as well 
as in clinical dermatology.  Exposure to DBD has promoted cell proliferation and 
migration while also sterilizing wounds and expediting blood coagulation.  Kalghatgi et 
al treated porcine aortic endothelial cells with low dose of non-thermal plasma.  Doses up 
to 30 seconds of treatment (4 J/cm2) caused cells to proliferate twice as much as 
untreated cells after five days post-treatment while doses 60 seconds (8 J/cm2) and longer 
lead to death apoptosis [104].    Rapid cellular proliferation following low dose treatment 
was accredited to a greater release of fibroblast growth factor-2 (FGF2).  Another group 
confirmed cellular proliferation following cold atmospheric plasma needle treatment of 
fibroblast cells simulating a wound via scratch test [105].  Both findings were conducted 
at low dose plasma discharge.  Other laboratories have tested various non-thermal 
discharges at higher doses and observed necrosis, cell detachment, and disruption of cell-
to-cell adhesion [106-108].  These results hold promise for treatment of cancerous cells 
and will be discussed in the following section.  Isbary et al studied the effects of non-
thermal jet plasma on bacterial colonization in slow healing wounds [109].  However, 
they were more concerned with the bacterial load of the wound following treatment and 
did not quantify the wound healing application of their device.  Instead they referred to 
the work done by Petykov et al, who used cold jet plasma on diabetic foot diseased 
patients.  Wounds treated with plasma experienced a reduction in pain after 5 days and 
healed in half the time as compared to control patients [110]. 
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 Atopic dermatitis (AD), or atopic eczema, can be a breeding ground for bacterial 
colonization and therefore likely increase the severity of the condition.  Non-thermal 
plasma has been used on AD, lowering the bacterial concentration while reducing the 
inflammation and irritation.  Mertens et al. used DBD plasma to treat patients with AD 
infected with Staphylococcus aureus.  Two days post treatment resulted in significant 
reduction of bacterial isolates in AD patients as compared to the control group [111, 112].  
In a separate study, similar findings were observed after plasma jet treatment of AD 
patients.  Confocal microscopy depicted eradication of Staphylococcus aureus without 
causing a reduction in the natural skin flora [112, 113].   
1.3.4.3. Plasma Applications in Cancer Therapy 
 When previous research groups witnessed cell necrosis, cell detachment, 
disruption of cell-to-cell adhesion, and apoptosis following high doses of non-thermal 
plasma [106-108, 114], the application of this technology in cancer therapy was 
considered for further exploration. 
 Fridman et al. first used DBD plasma to treat melanoma cells in vitro.  The group 
was able to inactivate cancerous cells by 80% one hour post treatment (30 seconds, 1.8 
W/cm2) and up to 95% when analyzed 24 hours following plasma exposure [115].  They 
also observed cellular apoptosis 2 days after low-dose treatment (5 seconds, 0.8 W/cm2).  
In a similar study, Kim et al used non-thermal jet plasma when studying anti-proliferative 
properties and cell death in human colorectal cancer cells.  They found severe inhibition 
of cell migration using standard scratch assay, nuclear condensation and DNA 
fragmentation using DAPI staining, and β-catenin degradation following plasma 
treatment [116].  Another group combined antibody-conjugated nanoparticles with non-
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thermal plasma in order to selectively treat cancer cells while avoiding treatment of 
normal cells. Alone, the nanoparticles were unable to provoke apoptosis in cancer cells 
while non-thermal plasma only generated a 20% reduction.  However, when the cells 
were pre-incubated with the nanoparticles and then exposed to a low dose DBD, 74% 
reduction in cell survival was reported [117].  Vandamme et al. evaluated plasma 
treatment of two human cancer cell lines, glioblastoma U87MG and colorectal carcinoma 
HCT-116.  Here, the ROS generated in the media containing cell lines following plasma 
treatment caused cell cycle arrest and induction of apoptosis [118].  They also reported 
reduction in tumor volume via bioluminescence in mice following in vivo non-thermal 
plasma treatment (Fig. 7).  Overall, non-thermal plasma has shown promise in the field of 
localized cancer treatment. 
 
 
Figure 7: Tumor reduction in mice following non-thermal DBD treatment [118] 
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1.3.5. Plasma Disinfection and Sterilization 
 Plasma disinfection and sterilization is the largest studied sub-field of plasma 
medicine.  Various non-thermal plasma have been used to disinfect planktonic and 
biofilm producing bacteria on surfaces, in liquids, and in air. 
 The first usage of atmospheric pressure plasma for sterilization of microorganisms 
was carried out by Laroussi et al less than 20 years ago [119].  The group reported total 
inactivation of Pseudomonas fluorescens in media after 10 minutes of plasma exposure.  
Since then, different sources of non-thermal plasma, as well as possible mechanism 
behind the phenomenon, have been explored.  Corona discharge in air has demonstrated 
inactivation of bacillus subtilis and Escherichia coli by 6-logs in less than 4 minutes 
[120].  Kelly-Wintenberg et al. used one atmospheric uniform glow discharge plasma 
(OAUGDP) on solid surfaces, fabrics, filter paper, and powdered culture media to 
successfully sterilize seeded Staphylococcus aureus, Escherichia coli, and Bacillus 
endospores [121].  Another group utilizing plasma jet with helium was able to inactivated 
7-logs of Bacillus globigii, an Anthrax surrogate, in just over 30 seconds [122].  The 
topic of non-thermal atmospheric pressure plasma decontamination has been extensively 
studied using many different discharge geometries [3, 123-126].  
 Bioaerosols, viable and nonviable biological particles suspended in air [127], have 
been known to cause adverse health effects in standard office buildings and healthcare 
facilities.  Current methods for the prevention of bioaerosol dispersion include High 
Efficiency Particulate Air Filters (HEPA), ultraviolet irradiation (UVGI), thermal energy, 
and ion emission [128, 129].  Recently, a specific type of DBD plasma, Dielectric Barrier 
Grating Discharge (DBGB), has been designed to inactivate bioaerosols [130, 131].  
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Gallergher et al created a DBD device consisting of 22 high voltage and 21 ground 
electrodes (Fig. 8).  The custom bioaerosol decontamination unit, a combination of the 
DBGB and a filterless ventilation system, produced a 1.5-log reduction in nebulized e. 
coli after a millisecond of direct exposure at air flow rates of 25L/s [130].  After a 
complete pass through the system (10 seconds), a 5-log reduction was reported.  The 
group further explored the mechanism behind such rapid sterilization results.  Ozone, 
assumed to be the longest living species generated by the system, only accounted for 10% 
reduction after 10 seconds of exposure.  Thus, the generation of reactive oxygen species 
and interaction with plasma filaments were responsible for the initial bacterial damage 
while the follow-up ozone treatment provided the complete sterilization effect [131]. 
 
 
Figure 8: DBGB electrode design [130] 
 
 
Plasma’s sterilization effects have been known since the early 1900’s, but the 
mechanistic explanation has been undetermined.  This lack of explanation is due to the 
conflicting and multiple hypotheses.  While one hypothesis might be proven to contribute 
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to bacterial inactivation, it would be incorrect to assume it is the only possible 
mechanism.  It is more than likely a combination of multiple products that create a 
synergistic sterilization effect.  Plasma produces the following products: 
1.3.5.1. UVC/VUV 
 UVC (ultraviolet type C) and VUV (vacuum ultraviolet) are known to sterilize 
surfaces covered with bacteria and other infectious microorganisms.  Wavelengths of 
300nm or less have been experimentally proven as the fatality threshold.  When 
generating plasma in the presence of different types of gases, different reactive species 
are produced.  This includes argon, air, synthetic air, and different mixtures of O2, O3, N2, 
and H2.  In present studies, we used DBD plasma that is generated at normal atmospheric 
pressure and room temperature.     
When bacteria are exposed to a range of UV wavelengths, the process of 
photodesorption is initiated.  During photodesorption, photons produced from UV 
irradiation stimulate the degradation of bacterial chemical bonds [132].  The 
microorganism continues to break down via etching by reactive species. The reactive 
species produced during plasma’s gas phase are adsorbed onto the microorganism’s 
surface and react to form new compounds [132].  These new oxidizing compounds are 
responsible for DNA mutation, and at higher doses, double strand DNA fragmentation.   
Many experiments, however, have disproved this hypothesis.  In one such 
experiment, bacteria were treated directly and indirectly with DBD.  To accomplish 
indirect exposure, culture dishes containing bacteria were placed in an opaque bag and 
exposed to DBD.  Surviving bacteria were almost identical between the two setups.  This 
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observation in part suggests that UV irradiation plays a negligible role in DBD 
sterilization, as the opaque bag would have blocked the UV light [133]. 
1.3.5.2. Reactive Oxidative Species (ROS) 
 Plasma formation generates more than just UV light.  Oxygen species, as well as 
oxygen-containing radicals, are formed.  This includes O, O2, O3 (ozone), OxHx, and NO, 
with x being any number of molecules used to form a stable, reactive compound.  
Researchers who disapprove of the UV irradiation hypothesis generally believe that 
oxidation is the true method of sterilization. 
Reactive oxygen species are highly bactericidal, produced by many antimicrobial 
agents, and also by prokaryotic and eukaryotic cells.  ROS are active free radicals and 
include peroxide, superoxide, and single oxygen.  Peroxide such as hydrogen peroxide 
(H2O2) generate hydroxyl radical (OH.), a highly toxic ROS, through Fenton reaction and 
Haber-Weiss reaction [134].  ROS can have a range of deleterious effect on both the host 
and bacterial cells, comprising a loss of membrane potential and membrane integrity, 
membrane lipid peroxidation, oxidative changes in cellular proteins and DNA. They have 
a capability of blocking DNA replication and transcription by causing single-strand 
breaks which accumulate within the cell [5, 135, 136].  Membrane lipid peroxidation is a 
method possibly pertaining to microorganism inactivation.  Oxidative species peroxidizes 
poly-unsaturated fatty acid (PUFA) chains found in the lipid bilayer of the membrane.  
PUFA loses a proton to the oxidizing radical, becoming a peroxyl radical.  Depending on 
the lost proton’s location, different steps might occur.  If the proton is lost on a terminal 
(end) location, chemical balancing occurs and a proton is taken from either another 
PUFA or Vitamin E, and a hydroperoxide molecule is formed.  If the proton is taken from 
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another PUFA, the cascade continues.  If the proton is taken from Vitamin E, the cascade 
stops.  Hence vitamin E is considered an extremely important antioxidant. 
 The original proton can be taken from within the PUFA, on an internal carbon.  
Cyclization occurs, creating a cyclic peroxyl radical.  The new cyclic peroxyl radical can 
now undergo further oxidation, similar to the terminal PUFA, and form multiple 
byproducts, including hydroperoxide.  The cyclic peroxyl radical could also undergo 
another cyclization before further oxidation, generating an intermediate structurally 
similar to prostaglandin endoperoxide.  This intermediate’s isomers include isoprostanes 
and malondialdehyde (MDA) [137] (Fig. 9).   
 
 
Figure 9: MDA formation pathway through membrane peroxidation [137] 
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 MDA can react with nucleic acid bases; forming bulky DNA adducts 
deoxyguanosine (M1G), deoxyadenosine (M1A), and deoxycytidine (M1C) (Fig. 10).  
These adducts can cause DNA mutation.  Normally, each pyrimidine has a corresponding 
purine, T-A and C-G.  Adducts cause base pair substitutions, such as transversions and 
transitions.  Transversions change the pyrimidine/purine pairs, creating T-G and C-A 
pairs.  Transitions generate pyrimidine/pyrimidine and purine/purine base pairs, such as 
T-C and G-A [138]. 
 
 
Figure 10: MDA generated DNA adducts [138] 
 
 DNA repair mechanisms are able to locate most of these mutations during DNA 
transcription; however, extensive damage could overwhelm the repair pathway.  Possible 
formation of nonsynonymous single nucleotide polymorphisms (SNP) can occur if repair 
mechanisms are unable to repair the adducts.  Nonsynonymous means an error in the 
code will generate different amino acids.  There are two types of nonsynonmous errors:  
missense and nonsense.  Missense errors in the code generate a completely different 
amino acid.  On the other hand, nonsense errors in the code cause a stop codon, resulting 
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in a shorter sequence [139].  Either error can cause irreversible damage to microorganism 
DNA, possibly effecting respiration, proliferation, and other metabolic processes. 
1.3.5.3. Sterilization of Living Tissue 
The primary question when applying plasma to living tissue is whether there are 
potential consequences regarding cellular toxicity.  Trials were conducted on cadaver and 
animal tissue, observing the effects of prolonged plasma exposure and possible side 
effects [100].  Cadaver tissue was treated with 5 minutes of continuous plasma without 
any visible or microscopic changes.  Mice were used to determine the maximum dosage 
(energy/time) of plasma that can be tolerated by living tissue.  After multiple trials, it was 
concluded that 10 minutes at 0.6 watts/cm2 was the maximum duration of prolonged 
direct treatment, while 40 seconds at 2.3 watts/cm2 was the maximum for high-power 
direct treatment [2].   Further studies to confirm non-damaging results include 
biochemical pathways and genetic analysis.  Toxicity of DBD plasma treatment is 
dependent on both the dosage as well as the applied voltage.   
1.3.6. Fluid-Mediated Plasma 
In fluid-mediated plasma application (under room air; no special gases or 
pressure) fluid such as phosphate-buffered saline (PBS) or solutions containing small 
organic molecules acquire strong antimicrobial properties upon plasma treatment.  This 
method is superior to direct plasma treatment and indirect jet plasma application since the 
body or other delicate surface does not contact the plasma discharge or plasma generating 
device. Our preliminary analysis of plasma-activated PBS solution suggests that 
antibacterial properties are broad-spectrum, inactivating a broad range of MDR 
pathogens, and predominately cause oxidative stress in E. coli.  The preliminary RT-PCR 
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findings also suggested the involvement of oxidative stress regulons oxyRS and soxRS.  
Therefore, we hypothesize that inactivation of E. coli using non-thermal plasma-treated 
PBS involves oxidative stress by redox sensing that is transcriptionally regulated by the 
oxyRS and soxRS regulatory systems. These regulons are responsive to generated ROS 
and their products, which leads to the oxidative changes that target cellular proteins and 
membrane lipid peroxidation resulting in DNA damage.  Both the oxyRS and soxRS 
regulons are directly sensitive to oxidation. Only oxidized regulons are capable of 
activating transcription.  Induction of these genes scavenge (to a threshold point) ROS 
such as superoxide, hydrogen peroxide or their products, thereby preventing further 
cellular damage (such as protein modification, lipid peroxidation, and oxidative DNA 
damage) by the formation of OH radicals via the Fenton reaction.   The goal of this study 
is to understand mechanisms underlying bactericidal effect of plasma-treated PBS 
solution, the chemical composition of the solution, and its cytotoxic effects in vitro and in 
vivo.   
1.4. Thesis Organization 
The present study has four specific aims.  The first two, which involves a genomic 
approach, especially oxyR regulon-mediated transcriptional responses, and the oxidation 
changes in critical cellular components that lead to E. coli cellular inactivation.  The third 
aim will explore the treated solution physically and chemically in order to determine 
active species and specific compounds responsible for its sustainable antimicrobial 
properties.  The final aim will test the cytotoxic effects of plasma-activated PBS when in 
contact with an in vitro cell line as well as in vivo procine studies of wound 
decontamination and healing.  The specific aims of this thesis are as followed: 
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• Establish a method for the generation of plasma-activated PBS solution and 
determine sub-lethal dose for E coli 
• Determine the oxidative changes in cell components of E. coli in response to 
treatment with plasma-treated PBS 
• Identify and quantify the chemical species produced in plasma-activated PBS 
solution 
• Demonstrate in vitro and in vivo safety of plasma-activated PBS solution 
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2. CHAPTER II:  KINETICS OF PLASMA-ACTIVATED PBS-MEDIATED 
INACTIVATION 
 
2.1. Introduction 
It is essential to understand what causes bacterial inactivation.  In this chapter, a 
sub-lethal dose of plasma-treated PBS, and its holding times with Escherichia coli, is 
optimized taking the following approaches:  
• Optimize the sub-lethal plasma-activated solution when exposed to E. coli. 
• Use of oxidative stress scavengers and oxidative stress defense gene deficient 
bacterial mutants to measure efficacy of specific reactive oxygen species. 
• Determine the oxidative changes in membrane lipids, membrane potential, and 
DNA oxidative damage in E. coli 
2.2. Materials and Methods 
2.2.1. Plasma Treatment of PBS Solution 
Non-thermal plasma was generated with an alternating current (AC) pulsed power 
supply (Advanced Plasma Solutions, Malvern, PA).  The power supply consists of a step 
up transformer that produces a high voltage between the output terminals. The 
microsecond plasma device produces a sharp discharge peak voltage, whose frequency 
and pulse duration can be adjusted.  Electrical measurements were conducted by using a 
high frequency high voltage probe (North Star PVM-4, 110 MHz, Marana, AZ) 
connected in parallel with the electrode and a high frequency current probe (Pearsons 
Model 2878, Palo Alto, CA) around the high voltage electrode wire.  The probe signals 
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were recorded using an oscilloscope (TDS5052B Digital Phosphor Oscilloscope, 
Tektronix, Inc., Richardson, TX). 
FE- DBD discharge was created by using a custom copper electrode insulated 
with Ultem (polyetherimide, McMaster-Carr) and covered with a quartz dielectric (d = 
3.5c m, t = 0.05 cm).  The area of the completed electrode, insulated housing and copper 
interior, was 11.4 cm2.  The discharge area, which occurred at the copper/quartz interface, 
was 5.17 cm2.  The design and fabrication were completed by A.J. Drexel Plasma 
Institute (Drexel University, Philadelphia, PA) (Fig. 11). 
 
 
Figure 11: Design and Dimensions of the Free-Floating Electrode used in Dielectric Barrier Discharge 
(FE-DBD) 
 
 
Sterile 1X PBS (125 µl) was deposited in a concave microscope slide (Fisher 
Scientific, Pittsburgh, PA) and placed under the FE-DBD.  The discharge gap between 
the electrode and surface of PBS was fixed at 2 mm.  Non-thermal plasma treatment of 
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PBS was optimized at 75 seconds. Power supply settings were as follows:  frequency at 
1.5 kHz, pulse duration of 10 µseconds, and wattage of 6.1 watts.  Based on the 
previously collected power supply characterization values, we calculated the power 
density (power transferred per unit area) and total energy applied per unit area of the non-
thermal plasma discharge.   
2.2.2. Bacterial Strains 
Escherichia coli (BW25113) and associated knockout strains (Table 5) were 
donated by Dr. Xilin Zhao (Public Health Research Institute, New Jersey Medical 
School, Newark, NJ).  Strains were stored as glycerol stocks at -80oC until needed.  
Revival of E. coli strains was carried out in 10 mL trypticase soy broth (TSB) (Fisher 
Scientific Inc, Pittsburgh, PA) and grown overnight for 16-18 hours in an orbital 
incubator (Innova 4300, New Brunswick Scientific, NJ).  Stock plates were prepared 
using trypticase soy agar (TSA) (Becton Dickinson, Franklin Lakes, NJ), incubated 
overnight, and stored at 4oC.  For experiments, fresh overnight cultures were normalized 
by spectrophotometer (ThermoScientific Multiskan, Fisher Scientific, Pittsburgh, PA) 
reading at 600nm and adjusting optical density (OD) to 0.2.  One hundred microliters of 
107 CFU/mL E. coli wildtype BW25113 were dispensed in a microcentrifuge tube and 
centrifuged at 8,000 RPMs for 5 minutes.  The resulting supernatant was aspirated and 
the remaining pellet was re-suspended in 100 µL of sterile water.  All experiments were 
performed in triplicate and repeated thrice, unless stated otherwise.   
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Table 5: List of E. coli Strains 
Strain Number Relevant Genotype Source/Reference 
BW25113 Wildtype Xilin Zhao/CGSC #7636 
3144 BW25113 ΔsodA Xilin Zhao 
3145 BW25113 ΔsodB Xilin Zhao 
3156 BW25113 ΔsodAsodB Xilin Zhao 
3157 BW25113 ΔkatG Xilin Zhao 
3201 BW25113 ΔkatGkatE Xilin Zhao 
3202 BW25113 ΔkatE Xilin Zhao 
 
 
2.2.3. Scavengers 
Water soluble vitamin E (D-alpha-tocopherol polyethylene glycol 100 succinate 
(Sigma-Aldrich, St. Louis, MO) was used as a universal oxidative stress scavenger, 
external catalase (catalase from Aspergillus Niger, Sigma-Aldrich, St. Louis, MO) was 
selected as a specific hydrogen peroxide scavenger, while thiourea (Sigma-Aldrich, St. 
Louis, MO) was used as a hydroxyl radical scavenger.  One hundred microliters of 50-
200 mM water soluble vitamin E, 20-200 units of catalase in 100uL of 1X sterile PBS, 
and 50-200 µM of thiourea in sterile water were pre-incubated with bacteria for 15 
minutes prior to plasma fluid interaction. 
2.2.4. Colony Counting Assay 
Samples were serial diluted (with PBS [pH 7.2]) and spread over trypticase soy 
agar (TSA, Fisher Scientific, Pittsburgh, PA) and incubated at 37°C for 18 to 24 hours. 
The percentage of surviving cells was calculated from the total count of colony forming 
units (CFU). For normalization, the CFU for untreated samples was set at 100% viability.  
The colony counting assay was performed to analyze the optimization of a sub-lethal 
plasma-treated PBS dose, the viability of the wildtype and gene deficient E. coli strains 
and the amount of protection offered by the water soluble vitamin E, catalase and 
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thiourea to the wildtype and gene deficient strains of BW25113 after exposure to plasma 
treated PBS 
2.2.5. Hydrogen Peroxide Detection Assay 
The amount of hydrogen peroxide retained in each sample was measured via 
Hydrogen Peroxide Detection Kit (National Diagnostics, Atlanta, GA).  A working 
solution of 20 mL was prepared by combining the two reagents given in the kit as per the 
manufacturer’s directions, and the assay was carried out in a 96-well plate. Serial dilutes 
of the treated PBS were prepared in order to determine specific hydrogen peroxide 
concentration.  One hundred microliters of plasma treated PBS (diluted and undiluted) 
were added in triplicate to each well.  The plate was allowed to incubate at room 
temperature for 30 minutes, after which spectrophotometric measurements were taken at 
560 nm, and normalized versus diluted 3% hydrogen peroxide (Sigma Aldrich, St. Louis, 
MO). 
2.2.6. TBARS Assay (Malondialdehyde Quantification) 
Detection of malondialdehyde (MDA) was quantified via OxiSelect TBARS 
Assay Kit (Cell BioLabs, Inc., San Diego, CA).  Following plasma treatment, samples 
and controls were centrifuged at 8,000 RPMs for 5 minutes.  The supernatant was 
aspirated and the remaining pellet was re-suspended in 100 µL of sterile water.  SDS 
lysis solution, 100 µL, was added to all samples and standards and incubated at room 
temperature for 5 minutes.  Following initial incubation, 250 µL of TBA reagent was 
added to all samples and standards, and tubes were then incubated at 95oC for 60 
minutes.  At the conclusion of the 60 minutes, tubes were moved to an ice bath for 5 
minutes and centrifuged at 3,000 RPM for 15 minutes.  Two hundred microliters of the 
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supernatant was aspirated and deposited in a 96 well plate.  Spectrophotometric 
measurements of the MDA-TBA adduct (Fig. 12) were taken at 532 nm.  MDA 
concentrations for each sample were normalized versus the negative (untreated) control.  
Different concentrations of hydrogen peroxide were used as a comparative positive 
control. 
 
 
Figure 12: MDA-TBA Adduct (http://www.cellbiolabs.com/tbars-assay) 
 
 
2.2.7. Bacterial Membrane Potential Assay 
Measurement of bacteria membrane potential following exposure to plasma 
treated PBS was carried out by BacLight Bacterial Membrane Potential Kit (Life 
Technologies, Grand Island, NY).  Following plasma treatment, samples and controls 
were centrifuged at 8,000 RPMs for 5 minutes.  The supernatant was aspirated and the 
remaining pellet was re-suspended in 1 mL of sterile water.  DiOC3 (3,3’-diethyloxa-
cyanide 3-chlorophenylhydrazone) was added to all tubes except one control, in order to 
normalize the baseline bacteria against the dyed samples.  Flow cytometry of samples 
were taken on the Guava EasyCyte Mini (EMD Millipore, Millerica, MA) and analyzed.  
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Results were quantified versus the negative (untreated) control after collection of 5,000 
events per sample. 
2.2.8. DNA Integrity and Oxidative Damage 
The cultures were exposed to untreated or plasma-treated PBS.  DNA was 
isolated from selected strains of E. coli BW25113, including wildtype, wildtype with 
catalase protection, ΔsodA, and ΔkatE following treatment.  Cultures were normalized to 
an OD of 0.2 and subjected to standard non-thermal plasma treatment protocol in 
triplicates of each condition.  DNA was isolated using DNeasy Blood & Tissue kit 
(Qiagen, Valencia, CA) following manufacturer’s protocol. 
Agrose gel electrophoresis (1%), with Ethidium Bromide, was run for the DNA 
samples and stained.  Isolated DNA was normalized to 10 ng/µL for all samples.  Each 
well was loaded with 10 µL of normalized isolated DNA and 1 µL of 5X loading dye 
(Bioline, Taunton, MA).  A 1kb DNA Ladder (Promega, Madison, WI) was used for 
scale.  Gels were run on a PowerPac Basic Power Supply (BioRad, Hercules, CA) for 45 
minutes at 100 volts. 
DNA oxidative damage was measured via 8-OHdG DNA Damage Quantification 
Direct Kit (Epigentek, Farmingdale, NY).  In a 96 well plate, 1 µl of the supplied 
negative control, 1µl of the supplied positive control, or 300 ng of isolated DNA was 
added to 80 µl of binding solution.  The plate was then sealed and incubated at 37oC for 
90 minutes.  After which the binding solution was aspirated from each well and washed 
three times with 1X wash buffer.  Fifty microliters of capture antibody was then added to 
each well, covered, and incubated at room temperature for 60 minutes.  Another 
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aspiration and three washings were performed.  Next, 50 µl detection antibody was added 
to each well and the plate covered, and incubated at room temperature for 30 minutes.  
Wells were once again aspirated and washed four times with washing buffer.  Fifty 
microliters of enhancer solution was added to the wells, covered, and incubated further at 
room temperature for 30 minutes.  The final washing step followed, the wells were 
aspirated and washed with buffer five times.  Developer solution (100 µl) was added to 
each well and held away from light for 1 to 10 minutes.  Stopping solution was then 
added to the wells in order to stop the enzyme reaction when the color of the solution 
started to change.  The microplate was then read at 450 nm within 2 to 15 minutes after 
the addition of the stopping solution. 
2.3. Results 
2.3.1. Optimization of Sub-lethal Plasma-activated PBS 
The optimization starting point was based on our previously completed direct 
treatment research.  We were unsure what power supply settings and treatment times 
were needed to produce a sub-lethal liquid solution.  Since we used lower frequencies for 
direct treatment, this was our starting point.  We kept pulse duration and treatment time 
constant, only varying the frequencies.  E. coli reference strain ATCC 25922 (American 
Type Culture Collection, Manassas, VA) was used during optimization experimentation. 
We learned that 30 seconds of treatment time did not provide any pattern 
regarding inactivation trends (Fig. 13A).  Initially, we had holding times of 1, 2.5, 5, 7.5, 
10, and 15 minutes.  This number was reduced due to extensive plating and allotted time.  
A frequency of 1.5 kHz was selected based on our initial findings.  Frequency and pulse 
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duration were kept constant, only increasing the treatment time of the solution.  We 
believed that we would reach a threshold point of pooled species in our small volume 
solution.  After 75 seconds of treatment, the desired trend of linear bacterial inactivation 
formed based on our selected holding times and colony forming units (Fig. 13B).   
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Figure 13: Optimization of sub-lethal plasma-activated PBS against E. coli survival by variation of (A) 
frequency and (B) holding time 
 
 
 We successful optimized our treatment of PBS and generated a semi-linear sub-
lethal dosage of plasma-activated buffer.  The final parameters were:  discharge distance 
of 2 mm, solution volume of 125 µl, discharge time of 75 seconds, frequency of 1.5 kHz, 
pulse duration of 10 µseconds, and wattage of 6.1 watts.  Power density was 1.8 W/cm2 
while applied energy was 88.5 J for 75 seconds of non-thermal plasma treatment. 
2.3.2. Sub-lethal Plasma-activated PBS Treatment of E. coli Wildtype BW25113 
 E. coli wildtype strain BW25113 was exposed to our newly determined sub-lethal 
plasma-activated PBS.  A linear reduction in cell viability was evident by E. coli wildtype 
BW25113 upon exposure to this sub-lethal dose of plasma-activated PBS (Fig. 14). 
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Figure 14: Sub-lethal plasma-activated PBS treatment of E. coli wildtype strain BW25113 
 
 
 It was observed that 1 minute of plasma-activated PBS treatment was able to keep 
>75% cell viability.  This short holding time was not adequate enough to provoke 
bacterial distress, thus causing inactivation.  After 5 minutes of E. coli exposure, only 
20% of the cells viable.  This time point is important as we saw proof of inactivation but 
not enough to sterilize the entire population.  There was no bacterial survival at 10 
minutes. 
2.3.3. Plasma-activated PBS Treatment, Sub-lethal Dose, and Effect of ROS 
Scavangers on E. coli Wildtype BW25113 
Here we investigated the effect of plasma-treated PBS against E. coli wildtype 
over a range of exposure (holding) times. The findings on E. coli inactivation after 1 min, 
5 min and 10 min is given in Figure 15. The responses compared to cells that were 
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exposed to untreated PBS for 10 minutes (we call here, 0 min plasma-fluid exposure 
time) to calculate a relative percentage of the cell survival.  Colony assay results reported 
30% and 80% reduction in cell viability after 1 minute and 5 minutes, respectively. No 
growth was observed on any plates for 10 minute exposed samples.  Parameter 
optimization experiments produced a semi-linear decrease in bacterial survival over the 
multiple time points.  The experiments were repeated between 3 to 5 times, without and 
with specific ROS scavengers (added prior to the plasma-treated PBS-bacteria 
interaction).  Vitamin E was chosen based on its global antioxidant properties, external 
catalase to provide specific protection against H2O2, and thiourea to target hydroxyl 
radicals.  All scavengers were investigated for optimal concentrations; vitamin E 
[200mM], catalase [200 units], and thiourea [100µM] provided significant protection 
from cell death due to oxidative stress. 
 
 
Figure 15: Bacterial viability of E. coli wildtype BW25113 after plasma-treated PBS with and without 
oxidative scavengers gave significant protection from cell death.  ** indicates p values of <0.005 and **** 
indicates p values of < 0.0001. 
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Interestingly, no scavenger was able to protect E. coli cells after 1 minute of 
exposure to plasma treated PBS, probably indicating a higher pool of ROS.  However, a 
significant increase in cell viability was noticeable after longer holding times, showing a 
2 fold increase in cell survival after pre-treatment with  α-tocopherol and a 3 fold increase 
with catalase at 5 minutes.  Thiourea showed no increase in cell viability when compared 
to the unprotected wildtype.  At 10 minute exposure time, the wildtype strain was 
completely inactivated without any form of external protection (scavengers).  The α-
tocopherol-protected samples showed 43% viability, pre-treatment with catalase 
promoted 72% survival, while thiourea only boasted an 18% in bacterial survival (Fig. 
15).  Since we saw the significant ability of a hydrogen peroxide-specific antioxidant to 
effectively protect over a global and a hydroxyl radical scavenger, this led to the belief 
that H2O2 may be the major ROS in plasma-activated PBS solution that actively 
participates in bacterial inactivation. 
2.3.4. Hydrogen Peroxide Detection 
 As a result, we measured the net concentration of H2O2 in plasma-treated PBS 
solution using a specific hydrogen peroxide detection kit.  The average amount of H2O2 
in our samples was 0.30 mM (± 0.03 mM) in 75 seconds plasma-treated PBS solution.  
This was much lower than originally estimated as our 0.01% H2O2 standard was 3.26 
mM.  While we hypothesize that hydrogen peroxide provides the primary mechanism of 
inactivation, the other ROS produced from plasma fluid still might be playing a vital role 
in cellular viability [118, 140, 141].  
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Figure 16: Hydrogen Peroxide Assay Standard Curve 
 
 
2.3.5. Membrane Lipid Peroxidation 
We previously determined that direct non-thermal plasma treatment of E. coli 
causes lipid peroxidation and formation of malondialdehyde (MDA), a bulky adduct that 
binds to DNA nucleotides and disrupts repair mechanisms, causing cellular death [5, 
137]. The formation of MDA could be due to direct physical interaction of plasma-
generated charged particles created during pulsed microsecond non-thermal plasma 
discharge [4, 5].  In order to determine whether bacterial inactivation involves membrane 
dysfunction and lipid peroxidation, we measured the presence of MDA after exposure to 
plasma-treated PBS.  At all plasma fluid holding times we saw small amounts of MDA 
formation (0.11 µM (1 min), 0.15 µM (5 min), and 0.07 µM (10 min)) as compared to 
untreated samples (H2O2 standard dilutions were included) (Fig. 17). Thus, it is observed 
that plasma activated PBS at sub-lethal doses also caused variable amounts of lipid 
peroxidation.  Non-thermal plasma-produced ROS plays a role in the formation of MDA 
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and the species either act upon the cell membrane directly or pass through (or penetrate) 
the outer membrane.  Therefore, we decided to check for changes in membrane potential.  
 
 
Figure 17: MDA Quantification after Plasma-activated PBS and Hydrogen Peroxide Treatment normalized 
against Negative (Untreated) Control 
 
 
2.3.6. Membrane Potential 
Membrane potential can affect the transport channels located on the surface and 
thus likely to affect permeability and the ROS migration across the layer without causing 
permanent membrane damage [142].  Bacteria exposed to 1 minute, 5 minute, and 10 
minute holding times with plasma treated PBS produced a decrease in red/green dye ratio 
in the presence of DiOC2 (3,3’-diethyloxa-carbocyanine iodide).  This is a sign of cellular 
depolarization.  Figure 18 demonstrates a significant depolarization of E. coli cells 
exposed to plasma-treated PBS sub-lethal dose, as compared to untreated cells. 
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Figure 18: Changes in E. coli membrane depolarization measured by flow cytometry after treatment with 
plasma-activated solution or hydrogen peroxide.  **, p < 0.005, compared to control (untreated) cells. 
 
 
2.3.7. Sub-lethal Plasma-activated PBS Treatment of Oxidative Stress-Gene 
Deficient E. coli Strains 
While demonstrating E. coli inactivation on plasma-fluid exposure and showing 
increased viability in the presence of ROS scavengers, we looked at specific genes known 
to protect the cell against oxidation and promote cell survival after treatment.  Strains 
deficient in superoxide dismutase (sodA and sodB) were selected to demonstrate their role 
in digestion of superoxide and the Fenton Reaction, and knockout strains of catalase 
peroxidase (katE and katG) were chosen to show the detoxification of hydrogen 
peroxide-like species. We found that single knockouts of either sodA or sodB, as well as 
the double deletion of sodAsodB, were more susceptible to death at 1 minute of exposure 
as compared to wildtype; and the inactivation was significantly higher after prolonged 
exposure to our plasma fluid (5 minutes and 10 minutes) (Fig. 19A).  Remarkably, the 
ΔsodB superoxide dismutase deficient mutant demonstrated higher viability and survival 
rate (30%) after 5 minutes of plasma-activated PBS treatment, compared to other strains 
of ΔsodA (12.5%), ΔsodAsodB (22.3%).  All sod deficient strains and wildtype strain 
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were unable to survive 10 minutes of plasma treated fluid.  There was no significant 
difference between wildtype and the catalase deficient mutants at 1 minute of plasma 
fluid treatment (Fig. 19B).  Unlike the variation of viability found in the single knockouts 
of the superoxide dismustase strains, both the ΔkatE and ΔkatG strains were substantially 
inactivated after 5 minutes of plasma fluid, giving just 5.6% and 2.9% survival of cells, 
respectively.  Once again the double knockout strain showed very little difference in cell 
survival as compared to wildtype strain during plasma fluid exposures. This phenomenon 
has also been documented by other groups studying oxidative ROS lethality with the use 
of antimicrobial agent [143]. These results have further confirmed our initial hypothesis 
on the importance of hydrogen peroxide and its role as the primary ROS responsible for 
cellular inactivation. 
 
 
Figure 19: Bacterial viability of deficient strains after plasma treated PBS exposure with and without 
external catalase scavenger. (A) sod knockouts no scavenger, (B) kat knockouts no scavenger, (C) sod 
knockouts + catalase, (D) kat knockouts + catalase 
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Similar to initial scavenging experiments, we pre-incubated deficient strains with 
external catalase [200 units] for 15 minutes prior to the addition of plasma treated PBS.  
The results suggested that external catalase was able to significantly protect these strains 
after 1 minute in side by side comparison to the protected wildtype (Fig. 19C).  The 
ΔsodB and ΔsodAsodB strains provided more protection than the wildtype for all 3 
plasma fluid holding times.  Only ΔsodA generated less protection at any one holding 
time, with 41.4% survival obtained at 10 minutes of exposure.  The catalase knockouts 
also showed significant increase in protection (Fig. 19D). Mutant strains ΔkatE and 
ΔkatEkatG maintained comparatively higher viability rates than the wildtype at all 
plasma exposure time points.  Strain ΔkatG recorded a value similar to that of the wiltype 
during protection, given respectively, 69.0% versus 68.3% survival rate at 10 minutes.  
Again, we noticed that double knockouts of ΔsodAsodB and ΔkatEkatG were able to 
maintain nearly 100% viability after all plasma exposure times when adequately 
protected with external catalase.  Overall, all strains showed substantial viability when 
protected with a specific scavenger of H2O2. 
2.3.8. DNA Integrity and Oxidative Damage 
So far, we have demonstrated the plasma-treated PBS as an antimicrobial agent, 
its ineffectiveness in the presence of ROS scavengers, lipid peroxidation of the bacterial 
membrane after exposure, and the fluctuation in viability of the deletion mutants of 
certain oxidative-stress defense genes.  Next, we explored the extent of damage to the 
DNA and the marker that attributes DNA fragmentation during exposure to plasma-
treated PBS. DNA was isolated from the selected strains which were exposed to plasma-
treated PBS and tested for their integrity and damage.  Qualitative analysis of DNA 
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integrity was measured by agarose gel electrophoresis and quantified by imageJ software.  
DNA integrity experiments of wildtype strain depicted a severe fragmentation gradient 
after 5 minutes of plasma fluid exposure, and only trace amounts of intact DNA was 
observed by 10 minutes exposure (Fig. 20A).  A similar trend was observed by ΔsodA 
strain under the same conditions. ΔkatE was more susceptible to DNA damage.  DNA 
band intensity of ΔkatE strain at 5 minutes exposure was noticeably lower than that of the 
wildtype and ΔsodA.  A positive correlation was observed between the DNA integrity 
and bacterial cell viability assays carried out earlier. Following our hypothesis, the bands 
generated with catalase-protected wildtype strain confirmed a complete protection of the 
DNA from damage during plasma-activated PBS treatment (Fig. 20A, B). 
 
 
Figure 20: DNA integrity after plasma treated PBS exposure by gel electrophoresis (A) and imageJ 
quantification (B) 
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Levels of 8-OHdG (8-hydroxy deoxyguanosine) were measured as an indicator of 
oxidative damage of DNA. At 1 minute we saw the expected trend of 8-OHdG formation, 
with a significant difference between the level of 8-OHdG in wildtype (0.014 ng) and in 
the ΔsodA and ΔkatE strains (0.038 ng and 0.087 ng, respectively).  This suggested that 
both sodA and catalase give protection to DNA from oxidative-stress mounted by plasma-
treated PBS exposure and external catalase prevents DNA damage (Fig. 21).  However, 
this trend was not seen after 5 minute onwards. There was negligible concentration of 8-
OHdG in all 3 strains at 10 minutes of plasma-fluid exposure, indicating that DNA is 
probably severely damaged by this time.  Addition of external catalase protected the 
wildtype strain from oxidative stress, and no trace of oxidized deoxyguanosine seen 
during 1 minute and 5 minutes exposure times, and 0.015 ng of 8-OHdG detected at 10 
minutes, which is comparable to the amount measured at 1 minute of unprotected 
wildtype.  The scavenger was able to protect DNA damage against all plasma-treated 
fluid exposure time points.  
 
 
Figure 21: Measurement of oxidative damage to bacterial DNA by 8-OHdG with standard error 
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2.4. Discussion 
 The importance of ROS and its oxidation capabilities of vital cellular components 
by antibiotic agent and the killing of bacterial pathogens have been thought for a long 
time, but only recently being recognized.  In many cases, ROS either synergizes 
antibiotic efficacy or mediates bacterial killing [144].  ROS, such as peroxide and 
superoxide, are freely diffusible inside bacterial cells, and once internalized, produce a 
series of oxidation-reduction reactions mediated by iron-sulfur clusters, flavoproteins, 
and the Fenton reaction, generating further short-lived but high amount of hydroxyl 
radical species [144].  In part this inactivation mechanism involves oxidation of the 
guanine nucleotide pool [145].  Addition of general scavenger α-tocopherol and peroxide 
scavenger catalase significantly reduced E. coli cell death, whereas thiourea, the 
scavenger of hydroxyl radicals, failed to inhibit significant cell inactivation.  This 
suggests that sufficiently high hydroxyl radical concentration may not be generated, and 
may not be a major underlying mechanism of inactivation. α-tocopherol inhibits free 
radical-mediated lipid peroxidation of the membrane and behaves like a ROS pan-
scavenger [5, 146], similar to quinone containing coenzyme. In contrary, catalase is 
specific and sensitive to H2O2 concentration, where it converts hydrogen peroxide to 
water.   
 Bacteria exposed to plasma-treated PBS resulted in low membrane lipid 
peroxidation and a change in membrane potential like that of hydrogen peroxide control. 
Involvement of lipid peroxidation is reported during plasma treatment of various 
biological materials [5, 147, 148] wherein a compromise in membrane potential, and 
eventual breach in continuity in the membrane observed.  For comparatively low lipid 
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peroxidation, one explanation lies with the overall energy applied to the liquid (smaller 
dose of plasma energy).  The goal was to apply a sub-lethal dose capable of stimulating 
defense pathways to study gene transcription without causing much damage to the 
cellular system under observation.  The various ROS contained in the plasma treated 
liquid could permeate the membrane without causing significant membrane damage 
[142].  The change in membrane permeability would be sufficient for these radicals to 
penetrate the bacterial wall [149]. Additionally, we reported earlier that the equimolar 
concentration of H2O2 generated during plasma treatments of fluid is not alone sufficient 
to completely inactivate E. coli cells, and a synergy of various ROS is likely occurring 
[6].  
 A close correlation exists between bactericidal activity and DNA damage [144, 
145, 150]. Therefore, oxidative DNA damage in presence of ROS pool can be a potential 
mechanism behind bactericidal effect in our study. We saw severe oxidative DNA 
damage occurring in conjunction with lipid peroxidation.  Here we believe that DNA 
damage could be result of a double hit phenomenon. Either the plasma-generated ROS in 
plasma-treated PBS would have passed through the membrane and oxidized DNA 
directly or the formation of lipid peroxidation and their eventual product [134] would 
have initiated oxidation and subsequent DNA damage, since polyunsaturated side chains 
of membrane lipids are especially vulnerable to free radical-initiated oxidation. It is 
believed that the decomposition of hydroperoxides that are mediated by transition metal 
ion catalysis form more reactive radical species such as hydroxyl radicals, peroxy 
radicals, and reactive aldehydes (malondialdehyde and 4-hydroxynonenal), lead to more 
oxidative changes [136, 151]. A substantial concentration of 8-OHdG obtained from our 
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samples indicate oxidative stress of the DNA by base modification rather than strand 
breaks. Formation of 8-OHdG can often lead to strand misreading, mutagenesis, and cell 
death [152]. While there is detection of 8-OHdG at 1 minute of exposure to plasma fluid, 
colony counting data shows minimal change in bacteria viability.  This is evident in our 
wildtype as well as deletion strain.  At this early time frame, the DNA repair mechanisms 
are usually efficient to maintain the DNA functionality and integrity.  Over longer 
exposure times, the levels of oxidized deoxyguanosine slowly decrease due to single and 
double strain breaks, resulting in total DNA fragmentation (Fig. 21).  While testing the 
wildtype strain we found that external catalase supplement could significantly prevent 
such DNA damage, even upon longer exposure times (5 min and 10 min), indicating that 
such DNA damage is induced by ROS. The gene dinI, encoding DNA damage-inducible 
protein, and members of recBCD complex (required in DNA recombination and repair) 
were also found up-regulated during microarray studies, DNA damage. During repeat 
experiments, we observed a significant amount of 8-OHdG in wildtype strain at 5 minute 
exposure as compared to deletion mutants of sodA and katE, which could not be justified 
at the point. The modified base 8OHdG is considered to be one of the oxidative DNA 
products that are induced by oxygen radicals and an indicator of DNA damage. It remains 
to be seen if E. coli, under plasma fluid generated ROS, experience both types of DNA 
strain breaks.  
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3. CHAPTER III:  EXPRESSION OF E. COLI OXIDATIVE DEFENSE GENES 
IN RESPONSE TO TREATMENT WITH PLASMA-ACTIVATED PBS 
 
3.1. Introduction 
E coli is a well-studied microorganism.  Earlier we used this model to 
successfully demonstrate oxidative cellular changes during direct plasma bombardment.  
Here we observed that plasma-treated PBS solution activates the oxyRS and soxRS 
regulon systems.  Hence, it is essential to study which genes are transcribed that regulate 
oxidative changes in prototypic cellular components when cells are exposed to plasma-
treated solution. 
• Evaluated E. coli gene expression patterns by microarray analysis 
• Determined the expression profiles of oxyRS and soxRS-induced gene 
transcription in E. coli by quantitative real time PCR. 
3.2. Materials and Methods 
3.2.1. RNA Isolation 
Pellets from the control or plasma treated samples were re-suspended in 50 µL of 
PBS. The procedure was repeated thrice to collect 150 µL of total cell suspension.  Three 
hundred microliters of RNA Protect (Qiagen, Valencia, CA) was added to each control 
and test sample, resulting in a total stock solution volume of 450 µL.  From the stock, 
150 µL was transferred to a new microcentrifuge tube.  The remaining 300 µL was 
moved to storage in -80oC.  The tubes were then vortex for 5-10 seconds and allowed to 
incubate at room temperature for 5 minutes.  Following incubation, tubes were 
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centrifuged for 10 minutes at 5,000 RPM.  RNeasy Protection Bacteria Mini Kit (Qiagen, 
Valencia, CA) was applied following centrifugation.  Both products were used to increase 
RNA stability and slow RNA degradation. The final eluted RNA was re-suspended in 30 
µL of RNase free water.  Concentration and integrity of the collected RNA was measured 
on a BioPhotometer Plus nanodrop machine (Eppendorf, Hauppauge, NY).  Following 
concentration measurements, DNA-free DNase Treatment Kit (Invitrogen, Grand Island, 
NY) was used to remove any remaining DNA fragments.  The final collected volume of 
RNA in RNase free water was 25 µL.  Total RNA concentration and integrity was again 
measured on the nanodrop, than normalized and aliquoted to 50 ng/µL in 20 µL of sterile 
RNase-free water.  The samples were stored in -80oC until required. 
3.2.2. Reverse Transcriptase 
PCR master mix was fabricated with thawed primers and stored in a 
microcentrifuge tube.  In PCR tubes, 20 µL of purified control/sample RNA was mixed 
with 20 µL of master mix.  The tubes were then transferred to an Eppendorf Vapo Protect 
thermal cycler (Eppendorf, Hauppauge, NY) and amplified for 30 cycles.  The entire 
reverse transcriptase process took approximately 2 hours, with the products maintained at 
4oC upon completion 
3.2.3. DNA Microarray 
GeneChip E. coli Genome 2.0 Arrays (Affymetrix, Santa Clara, CA) were used to 
analyze total gene expression after plasma-activated PBS treatment.  This array includes 
10,000 probe sets that record the expression for all E. coli genes.  RNA was isolated from 
bacterial samples following plasma-activated PBS treatment.  Complementary DNA 
(cDNA) was reverse transcribed from the normalized isolated RNA, fragmented, and 
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chemically labeled.  The array chips were hybridized with the fragmented and labeled 
cDNA, generating a 2-fold differentially expressed gene list.   
3.2.4. Primer Design 
Forward and reverse primers for oxyR, oxyS, soxR, soxS, sodA, sodB, katE, and 
katG were required for gene amplification.  DNA sequences for each gene were mapped 
using EcoGene (ecogene.org, University of Miami, Miami, FL).  Specific primers for 
each gene was developed by utilizing the primer design tool made available by the 
National Center for Biotechnology Information (ncbi.nlm.nih.gov, Bethesda, MD).  
Amplicon size for each gene was limited to 70-100 bp for qRT-PCR (Table 6).  Primer 
sequences were uploaded and purchased through Integrated DNA Technologies 
(Coralville, IA).  Primers were re-constituted to 100 mM in sterile water and stored at -
20oC until needed.  
 
Table 6: Real-time polymerase chain reaction primer sequences 
Genes Accession 
Number 
Forward Primers [5’-3’] Reverse Primers [5’-3’] 
16s 
rRNA 
EG30084 TGCCTGATGGAGGGGGATAA CCGAAGGTACCCCTCTTTGG 
oxyR EG10681 CCACAGTTGGACCGTACCTG AACTGGTGGGTCTGTGCTTC 
oxyS EG31116 CCTGGAGATCCGCAAAAGTTC GCGGCACCTCTTTTAACCCT 
soxR EG10957 GGATCGGCGCATTCATACCT TTACGCAACGGGCAATCACT 
soxS EG10958 CAAAAATCGGACGCTCGGTG TCAGACGCTTGGCGATTACA 
sodA EG10953 CCTGCCATCCCTGCCGTATGCTTA TCGATAGCCGCTTTCAGGTCACCC 
sodB EG10654 AAGATGCTCTGGCACCGCACATTT TAAACTGCGCTTTGAAATCGGCAA 
sodC EG13419 ATGACGGCATCGGTAGCTTT CCGGTAAACATGAAGGGCCA 
katE EG10509 TCCGACTGCCCTTACCATA GTTCGGTTCGTAATTCGCCG 
katG EG10511 CGATCTACAACCCGACCGAG ACAGACAGACCAGAATCCGC 
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3.2.5. Real-Time Polyerase Chain Reaction (RT-PCR) 
The cDNA concentration required for qPCR was 10 ng/µL, which was created by 
diluting 20 µL of the stock cDNA samples (50 ng/µL) in 30 µL of sterile water.  The 
remaining 20 µL of concentrated cDNA was stored at -20oC.  Forward and reverse 
primers were also dilute from 100 µM to 5 µM.  cDNA (1.25 µL) was loaded in triplicate 
in a PCR 96-well reaction plate (Applied BioSystems, Carlsbad, CA).  A master mix 
consisting of sterile deionized water, forward primers, reverse primers, and SYBR green 
PCR Master Mix (Applied BioSystems, Carlsbad, CA) was added by a volume of 8.75 
µL per well.  An optical adhesive cover (Applied BioSystems, Carlsbad, CA) was then 
fixed to the top of the plate and centrifuge at 3,000 RPM for 1 minute in order to draw the 
full 10 µL to the bottom of the wells and remove any air bubble formation.  The reaction 
plate was inserted into an Eppendorf RealPlex4 thermal cycler (Eppendorf, Hauppauge, 
NY) and run for 40 cycles at 1 minute and 15 second increments.  Total time of gene 
amplification and quantification took approximately 2 hours.  Raw data was collected via 
RealPlex4 software (Eppendorf, Hauppauge, NY) and analyzed in Microsoft Excel for 
comparative fold increase of genes. 
3.3. Results 
3.3.1. Microarray Gene Expression 
One minute plasma-treated PBS and a 15 min holding time were used on wildtype 
E. coli.  These parameters were pre-chosen as the microarray/plasma experiments 
reported here were part of a larger body of work.  After comparative analysis of 
microarray data of plasma-treated PBS mediated inactivation and the discrepancies in cell 
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viability in mutant E. coli strains, we hypothesized that our genes of interest (sod and kat) 
are significant up-regulated.  
 
Table 7: Significant Up and Down Regulated Genes after Microarray Analysis 
Gene Fold Increase Gene Fold Decrease 
oxyS 29 carB -14 
katG 19 putA -7 
grxA 11 uraA -6 
sufS 8 pyrD -6 
ahpF 7 putP -4 
ahpC 4 carA -3 
soxS 3 pyrC -3 
sodA >2 pyrB -3 
recN >2 pyrF -3 
recD >2 fliGIJNOP >-1.5 
nrdABEFGI >2   
dinI >2   
 
 
We observed that katG and sodA both were up-regulated after plasma-activated 
PBS treatment (Table 7).  We also observed two major ROS regulons up-regulated: oxyS 
and soxS.  OxyS is primarily transcribed due to hydrogen peroxide stress and produces a 
small untranslated mRNA, used in the repair of DNA/RNA when oxidative damage is 
present.  SoxS, controlled by autoregulation, activates 40 different genes responsible for 
the protection and digestion of superoxide and nitric oxide.  We also witnessed the up-
regulation of ahpC and ahpF genes (which play a role in peroxide digestion) and 2 rec 
genes (recN and recD; responsible for recombination and DNA repair). 
We also saw both carB (carbamoyl-phosphate synthase large subunit) and carA 
(carbamoyl phosphate synthase small subunit) are down regulated.  These genes play a 
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role in the formation of urea, which aids in metabolizing nitrogen containing compounds.  
PutA and putP play a role in proline catabolism.  Pyr genes C, B and F are all active in 
pyrimidine metabolism.  There were also a high number of flagella genes down 
regulated, including fliG, fliI, and fliP, which effect development and movement of the 
organism. 
3.3.2. Differential Expression of Oxidative Stress Genes in Wildtype E. coli 
Real time PCR was used to determine changes in gene expression for selected 
oxidative stress regulons and the genes that are transcribed by these regulons.  The delta-
delta-Ct, or ddCt, method was used to analyzed changes in gene expression [153].  
Values were then converted to base log 2 in order to differentiate between up and down-
regulated expression.  The wildtype strain produced substantial increase in expression for 
3 genes, oxyS, soxR, and katG, after 1 minute of plasma-activated PBS treatment (Fig. 
22A).  The oxyS and katG produced a 2.91 and 3.71 log 2 fold change, while soxR 
generated a 1.17 fold increase.  The expression levels of all genes were measured in the 
non-significant range for 5 and 10 minutes of plasma fluid exposure.  The over-
expression of oxyS and katG witnessed in the first minute of exposure further validates 
the presences of hydrogen peroxide in our system, as well as its importance in 
maintaining cell viability.  Interestingly, the over-expression of soxR also indicates the 
presence of other ROS radicals.  While superoxide and nitric acid may be present and 
generating a measureable response, it isn’t the primary regulon activated in standard 
wildtype conditions. 
Given the high levels of induction in oxidative stress response and our previous 
bacterial viability findings, we hypothesize that the addition of external catalase will 
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effectively prevent the activation of our selected oxidative stress regulons and defense 
genes.  We found that external catalase was able to successfully repress the over-
expression of oxyS and katG found during the treatment of our unprotected wildtype (Fig. 
22B).  However, the expression of soxR remained constantly over-expressed for all 3 
plasma-fluid holding times (1 min, 0.79 fold; 5 min, 0.92 fold; 10 min, 0.67 fold).  This 
suggests that overprotection against hydrogen peroxide formation could be placing more 
stress on alternative ROS defense pathways, but needs to be further analyzed. 
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Figure 22: Gene expression profiles (log 2 fold-change) in E. coli wildtype in the absence of presence or 
catalase for (A) regulon genes and (B) genes transcribed under the control of regulons showing in (A) 
 
 
 
Table 8: The levels of expression (log 2 fold-change) of relevant genes of E. coli Wildtype after Plasma-
activated PBS Treatment in the absence or presence of external catalase 
  Primer 
Strain Condition oxyR oxyS soxR soxS sodA sodB sodC katE katG 
Wildtype 1 minute -0.03 2.91 1.17 -0.31 -1.87 0.30 -0.47 -0.73 3.71 
5 minute -2.32 -1.66 -0.38 -2.02 -4.86 -2.60 -4.87 -2.22 -0.66 
10 minute -2.32 -0.90 -0.08 -0.76 -5.02 -4.48 -1.66 -1.74 0.41 
Wildtype 
With 
Catalase 
1 minute -0.70 -0.97 0.79 -0.21 -0.97 -1.23 0.03 -0.58 -0.5 
5 minute -4.15 -4.00 0.92 -1.64 -5.09 -4.32 -0.68 0.03 0.11 
10 minute -2.61 -3.05 0.67 -075 -5.93 -5.34 -1.98 -1.30 -0.83 
 
 
3.3.3. Differential Expression of Oxidative Stress Genes in Deletion Mutants of E. 
coli 
We next sought to determine the effects of plasma treated PBS on our previously 
studied oxidative stress defense deficient strains.  Expression of the regulons and 
transcription of genes of interest were obtained for all knockouts and compiled (Fig. 
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23A).  OxyS and katG were significantly expressed in all strains in which it was 
contained.  All deficient strains showed a fold increase in oxyS expression, the highest 
log2 fold change (4.30) occurring in ΔsodA at 1 minute of plasma fluid exposure.  The 
largest change for katG (4.77) was also found in the ΔsodA strain at the same time point 
(Fig. 23C).  Interestingly, katG was overexpressed at all time points when sodB was 
knocked out (log 2 folds 0.99 (1 min), 1.84 (5 min), and 0.58 (10 min)).  From this large 
collection of gene behavior, relationships between the pathways were made.  Not 
surprisingly, both sodA and sodB were overexpressed at all plasma holding times when 
neither katE or katG were present (Fig 23B).  However, the same cannot be said about 
katE and katG expression in the ΔsodAsodB strain.  Instead, we see constantly significant 
gene expression of the soxS gene in this knockout.  Besides significant fold increase in 
the wildtype at 1 minute, the over expression of soxR only occurs with the exclusion of 
either sodA or sodB.  Finally, in the absence of sodB, sodA was found to be significantly 
expressed. 
 
 
 
-6
-4
-2
0
2
4
6
1
min
5
min
10
min
1
min
5
min
10
min
1
min
5
min
10
min
1
min
5
min
10
min
1
min
5
min
10
min
1
min
5
min
10
min
1
min
5
min
10
min
Wildtype ΔsodA ΔsodB ΔsodAsodB ΔkatE ΔkatG ΔkatEkatG 
Lo
g2
 E
xp
re
ss
io
n 
vs
. U
nt
re
at
ed
 P
BS
 oxyR oxyS soxR soxS
A  
66 
 
 
 
 
 
 
 
Figure 23: Gene expression (log 2 fold change) of (A) oxidative stress regulons, (B) superoxide dismutase 
transcription genes, and (C) catalase genes 
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Table 9: Differential expression (log 2 fold-change) of common oxidative stress-response genes in 
wildtype and mutants of E. coli upon exposure to plasma-treated PBS 
    Primer 
Strain Condition oxyR oxyS soxR soxS sodA sodB sodC katE katG 
Wildtype 1 minute -0.03 2.91 1.17 -0.31 -1.87 0.30 -0.47 -0.73 3.71 
 5 minutes -2.32 -1.66 -0.38 -2.02 -4.87 -2.60 -4.97 -2.22 -0.66 
 10 minutes -2.32 -0.88 -0.08 -0.76 -5.02 -4.48 -1.66 -1.74 -0.41 
ΔsodA 1 minute -0.41 4.30 0.96 1.83 - -1.10 1.94 0.36 4.77 
 5 minutes -0.68 1.50 1.10 2.56 - -0.72 -1.29 -0.58 0.54 
 10 minutes -2.37 0.98 -0.15 -0.04 - -1.77 -2.26 -0.80 -0.50 
ΔsodB 1 minute -1.64 0.21 1.41 -0.40 -1.53 - -2.47 -2.75 0.99 
 5 minutes 0.14 3.63 2.55 -0.90 2.60 - 0.99 -1.34 1.84 
 10 minutes -2.36 -0.37 0.98 -0.03 1.66 - -1.43 -1.32 0.58 
ΔsodAsodB 1 minute -1.83 3.40 -0.17 1.38 - - 1.25 -1.31 2.12 
 5 minutes -2.86 -0.97 -1.10 2.85 - - -0.87 -0.66 -0.22 
 10 minutes -3.35 -2.93 -1.13 3.01 - - -0.38 -1.14 -0.42 
ΔkatE 1 minute -2.13 4.30 0.47 -3.14 -1.20 0.52 0.43 - 1.57 
 5 minutes -2.83 1.32 -0.71 -3.46 -1.65 0.81 -0.47 - -0.21 
 10 minutes -1.73 0.17 0.47 -4.41 -0.43 -0.41 -0.82 - -0.41 
ΔkatG 1 minute -2.11 3.47 0.15 -2.18 -0.75 -0.25 0.29 -1.41 - 
 5 minutes -2.66 0.83 -0.47 -1.41 -0.37 0.17 -0.80 -0.94 - 
 10 minutes -4.03 -1.77 -1.04 -3.09 -0.42 -0.25 0.25 -0.77 - 
ΔkatEkatG 1 minute -2.48 3.59 0.22 0.84 1.37 1.18 -0.29 - - 
 5 minutes -3.58 2.38 -0.98 -0.24 1.05 2.07 1.50 - - 
 10 minutes -3.94 -2.25 -1.40 -1.44 1.10 0.72 -0.46 - - 
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A comprehensive numerical chart of changes in gene expression of oxidative 
stress response gene deficient strains after plasma-activated PBS exposure can be found 
in Table 9. 
3.4. Discussion 
OxyR is a dual transcriptional regulator protein that senses oxidative stress and 
regulates antioxidant genes, katG (catalase), ahpC /ahpF (alkyl hydroperoxide reductase), 
and gorA (glutathione reductase), including its own regulation (oxyR). A hypersensitivity 
of oxyR deletion mutants to hydrogen peroxide demonstrates its importance in sensing 
H2O2 and for the subsequent antioxidant gene transcription [154, 155].  In addition, only 
oxidized oxyR activate the gene transcription required to protect cells from oxidative 
stress.  We have studied the oxyRS and soxRS regulons, which are primarily responsible 
for the activation of bacterial oxidative stress defense genes and most widely reported 
redox signaling systems.  We previously mentioned that oxyS is activated when 
DNA/RNA repair is required under oxidative stress.  This supports the findings of the 
presence of base modifications in DNA of cells treated with plasma treated PBS. Our 
microarray analysis of wildtype strain showed highest expression of oxyS (29 fold up-
regulation) and RT-PCR analysis also demonstrated a significant up-regulation of oxyS 
and katG during exposure to plasma-treated PBS. In studies with wildtype strain, the 
activation of oxyR and the transcription of oxyS and katG were found significantly 
inhibited in presence of catalase; indicate the scavenging of hydrogen peroxide-like 
species. The ahpCF peroxidase and the katG catalase directly limit H2O2 accumulation 
[156]. E. coli has two catalases:  HPI (hydroperoxidase I, encoded by katG), which 
functions as a primary scavenger of endogenous H2O2, and requires a transcriptional 
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regulator, oxyR, and HPII (hydroperoxidase II, encoded by katE) which is a key player in 
survival through stationary phase (via inducible RpoS regulation) and other stresses not 
induced by H2O2 [157].  During wildtype E. coli microarray and wildtype and mutant 
ΔsodA, ΔsodB and double deletion mutant ΔsodAΔsodB RT-PCR data analysis, we did 
not see transcription of katE, wherein oxyS, katG and ahpCF were highly up-regulated. 
This again indicates the involvement of oxyR regulatory control. The transcription factor 
oxyR also induces expression of mntH (encoding a manganese transporter) during H2O2 
stress, which we saw during microarray analysis of wildtype.  Manganese import is not 
required by E. coli cells to scavenge ROS or to protect DNA from oxidative damage, but 
required by the cell to protect enzymes such as MnSOD (encoded by sodA) [158].  The 
scavenging activity of Mn-containing enzyme exceeds the chemical activity of 
intracellular concentration of manganese by several orders of magnitude, and therefore 
Mn is not an efficient scavenger of ROS (but the enzyme Mn-SOD). The oxyR regulon is 
also involved in suppression of Fenton reactions (via Dps synthesis) and the oxidation of 
DNA [158, 159], and regulation of iron homeostasis through inactivation of Fur protein 
(required to restore the control of iron import). The Suf system, which helps to maintain 
the activities of Fe-S enzyme cluster, is also regulated by the oxyR regulon. Most 
components of Suf system were up-regulated during microarray analysis of our wildtype 
strain, but conversely, the proteins involved in iron transport were down-regulated and 
therefore a disruption of iron homeostasis can be expected. Inactivation of Fe-SOD by 
H2O2 has been observed earlier [160].  It is reported that just 0.1 µM intracellular H2O2 is 
sufficient to activate the oxyR regulon to exert its regulatory control in E. coli. In this 
context the amount of H2O2 we detected (0.30 mM in 100 µl after 75 seconds plasma 
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treatment) was sufficient to generate the require H2O2 pool inside cells, even upon a brief 
exposure time of 1 minute. 
 SoxR transcriptional regulator is responsible for the activation of soxRS system 
and is responsive to oxidative stress. In E. coli, the target gene for soxR is soxS, a 
transcription factor which promotes the expression of several dozen genes that play 
various roles in oxidative stress management in cells, and most notable among them are 
superoxide dismutases (encodes by sodA, sodB, sodC) and aconitate hydratase (encoded 
by acnA); both extremely sensitive to superoxide accumulation and /or nitric oxide stress. 
During microarray analysis we saw sodA (encoding Mn-SOD) (but not sodB and sodC) 
and acnA up-regulated (both > 2 folds). Hydrogen peroxide also causes a weak activation 
of sodA [161].  There is a significant overlap between the oxyR and soxRS regulons and 
other regulatory or global networks. For instance, sodA gene expression is carried out by 
four independent control systems [162].  During our wildtype E. coli studies, we saw that 
sodA (sensitive to superoxide anion) is strongly induced when plasma-treated PBS or 1 
mM of hydrogen peroxide (control agent) applied. In contrary to oxyR, in wildtype strain, 
the presence of catalase did not significantly inhibit the activation of soxR or transcription 
of soxS, sodA and sodC.  During deletion mutant studies, we saw activation of sodC in 
ΔsodA, ΔsodB and ΔsodAsodB, as well as in ΔkatE, ΔkatG, and ΔkatEkatG, indicates a 
compensatory mechanism of ROS stress management. Thus, it is possible that sodA 
transcription is a result of response to both the hydrogen peroxide and superoxide 
generated by plasma-treated PBS exposure, but may be operated independently of oxyR, 
under the control of soxRS regulons.  
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In E. coli, both Mn-SOD and catalase also mediates acid-stress resistance. 
Therefore, co-induction of superoxide dismutase and catalase in response to acid 
accumulation supports the notion that acid-stress and oxidative stress are related 
phenomena [163]. Plasma treated PBS solution is acidic, and therefore it is possible that 
this additional acid-stress may be synergizing oxidative stress to activate oxyR and soxRS 
regulons. The endogenous SOD levels control iron-dependent hydroxyl radical (HO.) 
formation when cells are exposed to H2O2, and largely depend on a continuous supply of 
Fe2+. The protection provided by Mn-SOD against H2O2 is likely by interfering with HO. 
generation, as we observed the higher transcription of sodA (encoding Mn-SOD) and no 
effect of specific hydroxyl radical inhibitor on survival on wildtype cells. Cytotoxic 
effects of acid stress and oxidative stress are remarkably similar [163], but a detailed 
study is required in this direction on plasma fluids. 
  Recently, soxR is found to inhibit guanine damage by replacing quinine radicals. 
Alternatively, soxR can be activated by the agents that are known to promote DNA 
damage, such as H2O2.  One of the early signals of oxidative stress inside cell is the 
formation of guanine radical in DNA, which can readily migrate to equilibrate at guanine 
sites of low oxidation potential, before irreversible oxidation occurs to form 8-OHdG and 
other base oxidation products [164]. Our observation on rapid appearance of 8-OHdG 
and concurrent activation of soxRS regulon may indicate a redox signaling relation.  SoxR 
transcription can be activated from a distance through DNA-mediated charge transport 
[164].  All together, we conclude that hydrogen peroxide is one of the predominant ROS 
in plasma-treated PBS, responsible for bacterial inactivation that activates transcription 
factors oxyS and soxRS, and leads to oxidative DNA damage in E. coli. 
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4. CHAPTER IV:  IDENTIFICATION OF REACTIVE OXYGEN SPECIES IN 
PLASMA-ACTIVATED PBS SOLUTION 
 
4.1. Introduction 
The chemical species and their product’s stability and concentration(s) over time 
are essential to determine and correlate.  Here we: 
• Detected and quantified the chemical products using electron paramagnetic 
resonance and free radical spin traps. 
• Determined the stability of the chemical products in solution(s) stored for 
different periods of time by using UV-Vis spectroscopy and pH measurements.   
4.2. Material and Methods 
4.2.1. Electron Paramagnetic Resonance (EPR) 
The specific method for characterizing free radical formation in biology and 
chemistry is detection by electron paramagnetic resonance (EPR).  Most reactive oxygen 
species (ROS) are considered “radicals” due to the possession of an unpaired electron.  
EPR analyzes these free radicals by measuring the behavior of unpaired electron spin 
when in the presence of an external magnetic field.   
Most free radicals are short lived, making it difficult to quantify the EPR signal 
without compromising the signal intensity in the process.  Spin traps can extend these 
small half-lives by binding to the radicals and producing a more stable adduct.  
Scavenging agents can be used to prevent certain species from forming, allowing us to 
determine the origin of a particular ROS.  Radical formation can either be a direct 
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product of non-thermal plasma treatment or an intermediate product chemically yielded 
from an alternate formed reactive species 
4.2.2. Free Radical Spin Traps 
5,5-dimethyl-1-pyrroline N-oxide (DMPO, Enzo Life Sciences Inc., Farmingdale, 
NY) was selected to detect OH formation. DMPO is the most popular and widely studied 
spin trap.  This particular trap can determine the presence of superoxide via the 
DMPO/OOH adduct and also identify hydroxyl radicals by the formation of DMPO/OH.  
However, usage of DMPO is not without its complications.   This non-specificity of 
radical detection can lead to overlapping and difficult to interrupt signals.  Also, the half-
life of DMPO-superoxide adduct is 45 seconds, where it then decays into the more stable 
DMPO-hydroxyl adduct.  1-hydroxy-3-carboxy-2,2,5,5-tetramethylpyrroline HCl (CPH 
hydrochloride, Enzo Life Sciences Inc., Farmingdale, NY) was selected to detect 1O2 
formation.   
4.2.3. Selected ROS Scavengers and Chelators 
D-Mannitol (Sigma Aldrich Co., St. Louis, MO) was used as a specific OH 
scavenger.  Addition of D-Mannitol would confirm the presence of any OH, whether it 
originated from initial plasma bombardment of PBS or through chemical reactions.  
Superoxide Dismutase (SOD, Sigma-Aldrich Co., St. Louis, MO) is a well-known 
internal and external scavenger of superoxide.  By adding SOD prior to plasma treatment, 
we can determine if superoxide is formed and what effect it has on the total concentration 
of OH.  L-histidine (Sigma-Aldrich Co., St. Louis, MO) was used as a scavenging agent 
for singlet oxygen. 
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4.2.5. Detection of Free Radicals 
In all experiments, 125 µL of sterile 1X PBS was treated as per our previously 
determined sub-lethal parameters.  A concentration of 0.8 M of either DMPO or CPH 
was added to the PBS prior to non-thermal plasma exposure.  Trials involving ROS 
scavengers were added prior to treatment.  Solutions were then exposed to non-thermal 
DBD plasma discharge for 75 seconds and transferred to a glass capillary.  An EPR 
spectrometer (E-12 spectrometer, Varian, Palo Alto, CA) was used to measure free 
radical detection.  All time between plasma treatment and EPR measurements were kept 
constant (< 5 minutes).   
Manganese oxide (Sigma-Aldrich Co., St. Louis, MO) is a stable free radical and 
can be used to quantify experimental EPR spectrum via standardization.  A known 
concentration of MnO was prepared and measured.  At a known dose, the MnO produced 
an EPR signal of a certain magnitude.  From this, the number of spins generated by the 
known concentration can be used as a mathematical standard.  The resulting calculation 
was used as a quantification standard for the experimental amounts of DMPO-OH, 
DMPO-OOH, and CPH-O measured after non-thermal plasma treatment.  The 
combinations of spin traps and scavengers are listed in Table 10. 
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Table 10: EPR Experimental conditions for determining specific ROS 
Solution Spin Trap Treatment 
Time 
Spin Adduct Scavenger Purpose 
125µl PBS 2 µl DMPO 75 sec DMPO-OH N/A Existence of OH 
125µl PBS 2 µl DMPO 75 sec DMPO-OH D-Man Confirm OH 
125µl PBS 2 µl DMPO 75 sec DMPO-OH SOD Verify whether origin 
of OH is superoxide 
125µl PBS 2 µl CPH 75 sec CPH-O N/A Existence of singlet 
oxygen 
125µl PBS 2 µl CPH 75 sec CPH-O L-His Confirm singlet 
oxygen 
N/A N/A N/A N/A MnO Quantification 
 
 
4.2.6. Ultraviolet-Visible Spectroscopy 
 Ultraviolet-visible (UV-Vis) spectroscopy measures absorbance of solutions over 
the spectrum of visible and near ultraviolet light.  The spectrometer shines a single beam 
of light at a predetermined wavelength at our sample.  An absorbance value was 
generated, recorded, and the light was then reset to a new wavelength with the process 
repeating itself.  This continued until the entire spectrum of light (200 nm-1000 nm) was 
exposed to the sample.  An absorbance vs. wavelength curve was generated from the 
collected data.  The values peak at certain wavelengths depending on the composition of 
the solution.  Based on these values, the identity of these compounds can be extrapolated 
based on the location of these peaks. 
125µL of sterile 1X PBS was treated as per our previously determined sub-lethal 
dose parameters.  In order to quantify the changes in compound formation, the treatment 
time of the solution varied.  Sterile 1X PBS was treated by DBD non-thermal plasma 
discharge for 5, 10, 15, 20, 25, 30, 60, 75, 90, 120, and 180 seconds.  Since the 
spectrometer requires a cuvette to measure the UV-Vis spectrum, a total volume of 1 mL 
was required.  UV-visible spectra were generated with a UV-Visible spectrophotometer 
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(ThermoFisher Scientific, Waltham, MA, USA) between 200 nm and 1000 nm 
wavelengths with 1 nm interval.  Untreated sterile 1X PBS was used as a blank for the 
UV-visible spectra of plasma-activated PBS solution.  Samples were stored at room 
temperature for 6 months.  Measurements of these samples were taken 1 day, 2 days, 3 
days, 7 days, 14 days, 21 days, 28 days, 1 month, 2 months, 3 months, 4 months, 5 
months, and 6 months post plasma treatment.  The extended time points confirmed the 
longevity of plasma formed compounds in PBS. 
4.3. Results 
4.3.1. Hydroxyl Radical and Superoxide Detection 
 DMPO was added to sterile 1X PBS prior to plasma treatment.  After 75 seconds 
of plasma exposure, 100 µl of plasma-activated PBS with DMPO was analyzed via EPR.  
Measurements were taken at a gain of 4. 
 
 
 
Figure 24: EPR analysis of plasma-activated PBS with DMPO (Bar = 10 Gauss) 
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The 4 smaller peaks represent DMPO-•OH/•OOH formation (Fig. 24).  The 3 large peaks 
could be an indication of singlet oxygen and will be explored later with a more specific 
spin trap.  D-Mannitol and external SOD were added separately to sterile 1X PBS and 
DMPO prior to plasma treatment.  The goal was to measure peak intensity degradation 
after the addition of various concentrations of scavenger.  This would help delineate the 
formation of DMPO-•OH/•OOH from direct production of hydroxyl radials and 
superoxide anion radical. 
 Addition of D-Mannitol would scavenge any hydroxyl radicals in the solution 
prior to binding with our DMPO spin trap.  If •OH is present, the signal should decrease 
in amplitude (Fig. 25).   
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Figure 25: EPR analysis of plasma-activated PBS with DMPO and A) 10mM, B) 100mM, and C) 1M of 
D-Mannitol. (Bar = 10 Gauss) 
 
 
A 50% reduction in signal is noticed with the addition of 10mM of D-Mannitol.  The 
signal continues to degrade by 75% of the original DMPO detection amplitude after the 
addition of 1 M D-mannitol solution (Fig. 26).  
A  
B  
C  
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Figure 26: Reduction of DMPO-•OH/•OOH signal with the addition of D-Mannitol 
 
 DMPO can also spin trap the conjugate of superoxide •OOH.  While the reaction 
rate of DMPO with •OH is much faster than with •OOH (109m-1·s-1 vs 102m-1·s-1 [165]), 
this occurs at a pH of 7.  Plasma-activated PBS has shown to produce a much lower pH 
(discussed later) which could alter these conversion rates.  Also, formation of DMPO-
•OOH quickly degrades into DMPO-•OH (Fig. 27). 
 
 
Figure 27: DMPO with hydroxyl radicals and superoxide anion radicals [166] 
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Therefore, the presence of superoxide while short lived can contribute to the formation of 
•OH radicals in solution.  This has been extensively studied and is known as the Haber-
Weiss reaction. 
·O2- + H2O2  ·OH + OH- + O2 
External superoxide was added to sterile 1X PBS and DMPO.  A reduction in 
signal amplitude would confirm the presence of superoxide and its role in •OH formation 
(Fig. 28). 
 
 
Figure 28: EPR analysis of plasma-activated PBS with DMPO and (A) 15 units, (B) 50 units, and (C) 100 
units of external SOD.  (Bar = 10 Gauss) 
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There was a 50% reduction in signal intensity following pre-treatment with 15 units of 
external SOD.  After 100 units the signal becomes close to negligible (Fig. 29).  This 
confirms that superoxide played in active role in DMPO-•OH/•OOH formation. 
 
 
Figure 29: Reduction of DMPO-•OH/•OOH signal with the addition of external SOD 
 
 
4.3.2. Singlet Oxygen Detection 
 CPH was added to sterile 1X PBS prior to plasma treatment.  After 75 seconds of 
plasma exposure, 100µl of plasma-activated PBS with CPH-O was analyzed via EPR.  
Measurements were taken at a gain of 20. 
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Figure 30: EPR analysis of plasma-activated PBS with CPH-O.  (Bar = 10 Gauss) 
 
 The triple EPR spectrum with a peak intensity ratio of 1:1:1 depicts the presence 
of singlet oxygen in our sample (Fig. 30).  This confirmed the broad 3 peak signal 
initially discovered in our DMPO findings. In order to verify that singlet oxygen was in 
fact produced in the PBS solution, L-histidine, a specific singlet oxygen scavenger, was 
added to the liquid in order reduce peak intensity.   
 
Figure 31: EPR analysis of plasma-activated PBS with CPH-O and (A) 100mM, (B) 250mM, and (C) 
500mM of L-histidine.  (Bar = 10 Gauss) 
A  
B  
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 As expected, the addition of L-histidine decreased the intensity of the CPH-O 
signal suggesting the presence of singlet oxygen in our system (Fig. 31).  There was a 
semi-linear decrease in singlet oxygen concentration as more L-histidine was introduced 
into the sterile PBS.  A reduction of 20%, 55%, and 80% signal intensity was noticed 
after increased scavenger addition (Fig. 32). 
 
 
Figure 32: Reduction of CPH-O signal with the addition of L-Histidine 
 
4.3.4. Quantification of Reactive Oxygen Species in Plasma-Activated PBS 
 ROS generated in plasma-activated PBS was quantified by using a manganese 
oxide (MnO) standard.  An EPR signal of MnO was measured with an initial known 
concentration.  The resulting amplitude of the line spectrum was then used to calculate 
the number of spins generated at this concentration.  The peak-to-peak amplitude of our 
plasma-activated PBS EPR signals was measured, multiplied by the gain, and divided by 
the number of spins in our MnO standard (3.6·1016 spins).  The resulting value was the 
number of free radicals in our measured samples of 100 µl.  The molarity of the solution 
was further calculated by dividing our number of spins by 6·1019. 
0
20
40
60
80
100
0 mM 100 mM 250 mM 500 mM
CP
H-
O
  F
or
m
at
io
n 
(%
) 
L-Histidine Concentration 
84 
 
 
Table 11: Concentration of ROS and solution molarity of plasma-activated PBS 
 
 
Table 12: Concentration of plasma-activated PBS ROS versus microjet treatment of water 
   Plasma-activated PBS 
Solution 
Microjet Treatment of 
Water [173] 
Hydroxyl Radicals  5.40 x 10-4 M 1.20 x 10-5 M 
Singlet Oxygen  2.03 x 10-4 M 6.00 x 10-4 M 
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4.3.5. UV-Vis Spectrum Analysis of Plasma-activated PBS after Extensive Storage 
Times 
 Following the successful detection and quantification of singlet oxygen, hydroxyl 
radicals, and superoxide in plasma-treated PBS by EPR, the cause of the solutions long 
term bactericidal effects was explored.  All three of these detected reactive oxygen 
species have half-lives in the microsecond range.  While we previously measured the 
presence and concentration of hydrogen peroxide in our plasma-activated solution (0.30 
mM, Chapter 2), it was comparable to a 0.001% H2O2standard.  Yet this solution has 
maintained its antimicrobial properties.  Therefore, we must explore the possibility of 
other long living compounds capable of stabilizing our plasma-activated solution. 
 1 mL of plasma-activated solutions, treated with different dosages of plasma, was 
analyzed via ultraviolet-visible spectroscopy over a 6 month span.  The first 8 graphs 
covered various times of UV-Vis analysis throughout the first month of long term storage 
(Fig. 33A-H).  There was no visual change in peak intensity up to 28 days of post 
treatment storage.  There was one consistent peak at 302nm for all samples.  
Interestingly, there was a second peak for our shortest treated buffer (30 seconds) at 355 
nm. 
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Figure 33: UV-Vis measurements of plasma-activated PBS solution at various treatment times (A) 0, (B) 
1, (C) 2, (D) 3, (E) 7, (F) 14, (G) 21, and (H) 28 days post treatment 
A  B 
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Following the first 28 days, samples were analyzed monthly (Fig. 34I-N).  Again, 
there was no change in peak intensity for various treated solutions up to and including the 
6 month time point.  We also noticed the secondary peak initially found in our 30 second 
treated sample has now reduced to near zero.   
 
 
Figure 34: UV-Vis measurements of plasma-activated PBS solution at various treatment times (I) 1 month, 
(J) 2 months, (K) 3 months, (L) 4 months, (M) 5 months, (N) 6 months post treatment 
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 After 6 months of data collection, we noticed the stability of peak intensity at 
302nm (Fig. 35).  This peak was mainly attributed to HNO3 [86].  We were able to 
correlate the intensity values with a concentration using the Beer-Lambert Law.  The law 
was expressed by the following equation: 
A = ε • l • c 
Where A was absorbance, ε was the specific extinction coefficient (M-1·cm-1), l was the 
path length that light passes through (1 cm), and c is the concentration of the compound.  
The extinction coefficient for HNO3 was 70 M-1·cm-1 at 300 nm [167]. 
 
 
Figure 35: Peak intensity at 302 nm for plasma-activated PBS over 6 months storage time with standard 
error 
 
Not surprising, we saw an increase in HNO3 formation as treatment time of our plasma-
activated solution increased (Fig. 36).  The sub-lethal plasma dose we used in our earlier 
bacteria experiments (75 seconds) generated 6.00 mM of HNO3 in 1 mL of PBS.   
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Figure 36: Concentration of HNO3 in plasma-activated PBS over 6 month’s storage time with standard 
error 
 
 While the main stabilizing product of plasma-activated solution was HNO3, we 
still needed to explore the formation of the initial 355 nm peak in the 30 second treated 
sample.  Short plasma treatment times were utilized: 5, 10, 15, 20 and 25 seconds.  Two 
interesting trends developed:  the formation of 4 individual peaks after 20 seconds of 
treatment and the disappearance of these peaks 24 hours post treatment.  The peak of 
interest increased as one large peak for 5, 10, and 15 seconds (Fig. 37A).  However, after 
20 seconds of plasma treatment the one solid peak transitions into 4 smaller consecutive 
peaks.  After 25 seconds the peak disappeared entirely.  When analyzed 24 hours after 
plasma treatment, peak intensities for 5, 10, and 15 seconds remained consistent with 
those measured immediately following treatment (Fig. 37B).  Interestingly, the 4 smaller 
peaks found in our initial 20 second sample were now reduced to almost negligible 
values, similar to the reduction of the 25 second samples.   
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Figure 37: Peak intensity at 302 nm (HNO3) and 355 nm (NO2- and HNO2) following short PBS exposure 
to non-thermal plasma discharge (A) 0 and (B) 1 day after treatment 
 
 
 The peak at 355 nm was attributed to a combination of NO2- and HNO2 based on 
pH-dependency [168].  At pH measurements higher than 4.5, NO2- is primarily 
responsible for the UV-Vis absorption spectra at 355 nm.  When the pH of the solution 
reaches 3.5, we started to see a 1:1 ratio of HNO2 and NO2- concentrations and an 
overlapping spectrum developed as NO2 is converted to HNO2 [168, 169].  Plasma 
treatment of the solution greater than 25 seconds generates enough ROS to further 
oxidize the unstable HNO2 into HNO3.  Samples measured after 1 day of storage show 
similar amounts of NO2-, however, the unstable HNO2 still oxidized to HNO3 over time. 
 pH measurements of the samples were taken to confirm the pH drop following 
short duration plasma treatment of PBS (Fig. 38).  After 20 seconds of treatment, the pH 
of the plasma-activated solution was 3.6 on day 0 and 3.3 on day 1.   
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Figure 38: pH measurements of plasma-activated PBS solutions 
 
4.4. Discussion 
 EPR is a method for free radical detection in solid or liquid phase.  However, 
most free radicals have half lives in the microsecond range and require additional 
reagents to extend their presence before degradation.  Spin traps bind to free radicals, 
extend half-lives, and allow detection.  DMPO is commonly used to trap and measure 
hydroxyl radicals.  Even with DMPO preserving •OH, the half-life was only extended for 
10 minutes [170].  Few groups have explored EPR to detect and quantify ROS generated 
by plasma discharge.  Tresp et al used DMPO when detecting free radicals in liquid 
treated with argon jet plasma [166].  To ensure a proper signal, they tested multiple 
DMPO vendors (Fig. 39.)   
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Figure 39: EPR signal of DMPO-•OH before and after plasma treatment from different vendors [166] 
 
While they chose DMPO from vendor C when carrying out further experimentation, our 
signal looked similar to that of vendor B.  Tresp goes on to explain that the second three 
peak radical occurring between the four peak •OH signal is related to a methyl radical 
(CH•3) and must have originated from the trap as the solution in use (water) did not 
contain any carbon-based molecules [166].  This is a reasonable conclusion as plasma 
treatment itself could damage the spin trap.  This is more likely with a direct DBD set up 
than indirect argon plasma jet, as microfilaments in DBD could physically damage the 
trap.  However, the signal produced by vendor B in Figure X and that which we obtained 
with our own DMPO in Figure 24 are not identical.  Our second three peak radical looked 
very similar to the singlet oxygen signal detected with CPH-O.  Figure 27 displayed the 
change in DMPO’s molecular structure depending on its affinity to •OH and •O2-.  There 
is also a change in the nitrogen-oxygen bond.  The oxygen now has a free electron which 
is able to orbit between nitrogen and oxygen.  Nitrogen-14 has an odd number of protons 
and neutrons, creating a nuclear spin of plus or minus ½.  This gives the nucleus a 
magnetic spin of plus or minus 1 [171] (Fig. 40). 
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Figure 40: Electron spin and nuclear spin of nitrogen 
 
 When placed in a magnetic field, free radicals are paramagnetic and are attracted 
to the magnetic field due to the unpaired electron.  The summation of total electron spin 
can be calculated by the equation of multiplicity [172]. 
2S + 1 
2 [(+1/2) + (+1/2)] + 1 = 3 
In a triple state, an EPR spectrum of 3 peaks can be expected.  This was evident in both 
DMPO and TEMPONE-H spectra following plasma treatment of PBS with each spin 
trap. 
 Wu et al also explored ROS formation after non-thermal indirect helium jet 
plasma treatment of water [173].  Similar traps were used for hydroxyl radical (DMPO) 
and singlet oxygen (TEMP) formation.  By using D-Mannitol, external SOD, L-Histidine, 
and 9,10-anthracenedipropionic acid (ADPA) they were able to block the formation of 
•OH, O2-, and 1O2 in their system.  They quantified the ROS production by using known 
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TEMP concentrations and creating a standard curve.  This type of plasma system 
generated 6·10-4 M of singlet oxygen and 1.2·10-5 M of hydroxyl radicals [173]. 
 Both indirect jet plasma groups produced similar species to that generated by 
DBD plasma-activated PBS.  However, the nature of direct treatment versus indirect 
treatment was evident.  Direct treatment of liquid containing a particular spin trap could 
lead to dissociation and damage to the trap itself.  DMPO used by all groups came from 
different vendors, which has shown to cause different line spectrum formation and the 
possibility of secondary ROS being detected [166].  We saw this first hand with detection 
of singlet oxygen in both traps.  DMPO does not delineate between hydroxyl radicals and 
superoxide, raising the question of which ROS leads to a greater production of DMPO-
OH: direct trapping of •OH or the decay of superoxide as •OOH to •OH.  A third spin trap 
could be used to detect only superoxide.  BMPO has shown to react with superoxide at a 
rate 77M-1s-1 [174].  The use of this trap, in collaboration with those previously studied, 
would help individually quantify hydroxyl radicals and superoxide. 
 UV-Vis spectroscopy generated a peak at 302 nm for all plasma treatment times 
of PBS.  Peak intensities remained consistent at this wavelength for plasma-activated 
PBS storage times of > 6 months.  Since the ROS generated by direct DBD treatment of 
PBS are short lived, the stabilizing compound must have formed from different origins.  
Formation of reactive nitrogen species (RNS) could be an alternative source of 
antimicrobial properties in plasma-activated liquid and play a role in its long term 
effectiveness.  Nitric oxide, a known product of non-thermal plasma discharge at 
atmospheric pressure, serves as a precursor for nitrate and nitrite which acidifies liquid 
mediums [76, 175, 176].  Since plasma-activated PBS achieved a pH of 3.55 after 25 
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seconds of treatment and 1.99 (±0.09) after 75 seconds, the presence of nitrate and nitrite 
was likely.  Generation of nitrogen dioxide (NO2) in liquid can also give rise to nitric acid 
(HNO3) and nitrous acid (HNO2).  Nitric acid is considered a strong acid and very stable 
in acidic conditions.  Nitrous acid is a weak acid and easily converted to NO2, NO, and 
water.  However, if it is present in an acid environment and great in concentration, it can 
convert to HNO3, N2O, and water [177].   Nitrate absorbs from 290 to 330nm with a 
maximum absorption at 302 nm, while nitrite has a maximum absorption at 354 nm 
[178].  NO2 absorbs in the 370 – 460nm range [179].  We saw a substantial presence of 
HNO3 at 302nm.  In shorter treatment times, a second peak was detected around 355nm.  
This peak increased in amplitude after 5, 10, and 15 seconds of non-thermal plasma 
treatment.  However, at 25 seconds this peak now became a series of 4 smaller peaks.  
Arakaki et al saw a similar trend when studying aqueous-phase N(III) (HNO2 and NO2-) 
[168].   
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Figure 41: (A) Changes in absorption spectra based on pH values and (B) free radical formation based on 
acid dissociation constants [168] 
 
As pH dropped, the spectra noticeably changed from one to four peaks (Fig. 41A).  N(III) 
absorption differentiated depending on the solvent being polar or nonpolar.  Therefore, 
the absorbance spectra of HNO3 and NO2- are expected to different based on the extra 
proton in nitric acid [168, 180].  Interestingly, they also saw an increase in •OH formation 
as NO2- transitioned to HNO3 (Fig. 41B).  The production of more •OH in the presence of 
a weak acid such as HNO2 could lead to the final product of HNO3, giving rise to the 
prominent peak at 302 nm noticed in plasma-activated PBS samples. 
 Kojtari et al detected HNO3 and HNO2 when using DBD plasma on water [86].  
While their peak intensities of both compounds were much lower than those reported in 
this study due to an increased volume of treated liquid and a change in electrode 
geometry, the UV-Vis spectra of deionized water following plasma treatment matched 
the spectra of plasma-activated PBS.  They concluded that peroxynitrite is potentially the 
A  B  
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cause of long term antimicrobial stability, however were unable to identify its presences 
by UV-Vis or Raman spectroscopy due to overlapping signals and low concentrations 
[86].  Further research of peroxynitrite in plasma treated solutions is currently under 
investigation. 
 Plasma-activated PBS contains a variety of ROS and RNS such as singlet oxygen, 
hydroxyl radicals, superoxide, nitric oxide, nitrate, nitrite and peroxynitrite.  
Acidification of treated liquid gives rise to HNO3 and HNO2.  There is likelihood that 
these generated species work synergistically to form a robust antimicrobial agent capable 
of inactivation through a host of biological pathways. 
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5. CHAPTER V:  LOCAL AND SYSTEMIC TOXICITY OF PLASMA-
ACTIVATED PBS SOLUTION 
 
5.1. Introduction 
 Plasma-activated PBS at predetermined settlings showed lethality at 10 minutes of 
holding time with wildtype E. coli.  In order to use this solution topically or parenterally, 
we observed its effects on eukaryotic cells.  In this chapter the systemic toxicity and in 
vivo safety of this solution is presented, a step required for commercial development.  
The following aspects were studied: 
• Determined the cytotoxicity of plasma-activated PBS solution in cell culture 
• Determined in vivo tissue toxicity, wound sterilization and wound healing of 
plasma-activated PBS solution in porcine model. 
5.2. Methods and Materials 
5.2.1. Rat Aortic Cells (RACs) 
Rat aortic cells (RAC) were generously donated by Dr. Boris Polyak’s lab.  These 
primary cells were harvest and characterized by Dr. Mikhail Medved.  Cells were seeded 
in Gibco DMEM 1x (+4.5g/l D-glucose, + l-glutamine, -sodium pyruvate) complete with 
10% FBS (Fisher Scientific, Pittsburg, PA) in T-75 cell culture flasks.  After reaching 80-
90% confluence, RACs were trypsonized, centrifuged, and re-suspended in media.  Using 
a hemocytometer, 5 µl of cell suspension was placed in the viewing area and counted.  
Three 24-well plates were needed to test cellular response after plasma-activated PBS 
exposure for 0, 1, and 2 days post-treatment.  Ten thousand cells were seeded in 16 of the 
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24 wells for all 3 plates.  Experiments initiated as soon as each well achieved 85-90% cell 
confluence. 
5.2.2. Plasma-activated PBS Treatment of RACs 
Upon reaching confluence, the media was aspirated and cells were washed with 
sterile 1X PBS.  Plasma-activated PBS (100 µL) was applied for 1 minute, 5 minutes, and 
10 minutes in triplicate.  Following treatment times, RACs were washed with 400 µL of 
serum containing media in order to quench the effects of the plasma fluid (Fig. 42).  The 
media again was aspirated and cells were washed with sterile 1X PBS.  RACs were 
analyzed following treatment, 24 hours post treatment, and 48 hours post treatment.  
Cells which were to be immediately analyzed were processed for various assays and 
analysis.  The remaining samples were re-suspended in 300 µL of serum media and 
placed in a CO2 incubator at 37OC for further growth until time of analysis.  Cells were 
measured for membrane integrity, cellular respiration, and nucleic acid staining. 
 
 
Figure 42: An experiment showing rat aortic cells exposed to plasma-activated PBS 
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5.2.3. Live/Dead Viability Assay 
Live/Dead viability assay (Life Technologies, Grand Island, NY) can determine 
cell populations based on membrane integrity.  The assay contains two nucleic acid 
staining dyes: SYTO 9 and propidium iodide.  SYTO 9 fluoresces green and labels all 
cells regardless of its membrane intensity.  Propidum iodide, a red fluorescent dye, only 
labels cells with membrane damage.  Cells that uptake both dyes see a reduction in SYTO 
9 fluorescence.  Therefore, cells with intact membranes fluoresce green while those with 
damaged membranes fluoresce red.  Both powdered components are pre-packaged in 
micropipets and added to 5mL of sterilize H2O to form the working solution.  The 
working solution and cells incubating in the presence of the dye must be covered as the 
dye itself is light sensitive. 
After plasma fluid treatment, cells were washed with sterile 1X PBS and 
aspirated.  Serum containing media (100 µl) and the working solution (100 µl) were 
added to RAC containing wells and incubated for 15 minutes at room temperature away 
from light.  Following incubation, cells were analyzed by fluorescent spectroscopy and 
microscopy.  Excitation/Emission wavelengths for SYTO 9 are 485/530 nm.  Propidium 
iodide was detected via fluorescence at an excitation/emission reading of 485/630 nm.  
RACs were measured for both emission wavelengths with a microplate reader (BioTek, 
Winooski, VT) and analyzed by dividing the fluorescence intensity of SYTO 9 by the 
fluorescence intensity of propidium iodide.  This live/dead ratio was normalized versus 
the control group (untreated cells) to measure the relative increase or decrease in cellular 
membrane integrity post plasma fluid treatment.  After spectroscopy measurements, cells 
were viewed by fluorescent microscopy.  Images were captured by the EVOS FL Color 
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Imaging System (Life Technologies, Grand Island, NY).  RACs were examined under 
both GFP and RFP channels and overlaid to depict a composite image of live and dead 
cells. 
5.2.4. Cellular Respiration Assay (XTT) 
Tetrazolium salt assays (XTT:  2, 3-Bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide) (Sigma-Aldrich Co., St. Louis, MO) was used to measure 
cell proliferation and cytotoxicity [181, 182].  Respiring cells convert tetrazoliums to 
formazans through reduction (Fig 43).  The newly formed formazans produce a visible 
color change in the presence of cells and can be measured by spectroscopy.  XTT, in 
combination with an intermediate electron acceptor, improves the rate of formazan 
conversion.  Menadione was chosen as the intermediate.  Stock solution of XTT dye 
contained 50 µl of 50 µM XTT per milliliter and 1 µl of 5 µM menadione per milliliter in 
serum free HyClone RPMI media (Fisher Scientific, Pittsburg, PA). 
 
 
Figure 43: Reduction of XTT to formazan due to cellular respiration 
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Like the Live/Dead assay, RACs were washed with sterile 1X PBS and aspirated 
following plasma fluid treatment.  Cells were covered with 250 µL of XTT/menadione 
stock solution and incubated for 2 hours at 37OC.  The microplate was covered as the 
XTT/menadione dye is light sensitive.  After incubation time, the dye was measured for 
absorbance at 492 nm by spectroscopy (BioTek, Winooski, VT).  The data was 
normalized versus the control (untreated) samples to measure the change in cellular 
respiration following plasma-activated PBS treatment. 
5.2.5. Nucleic Acid Hoechst Stain 
Hoechst, or bisbenzimide, is a cell permeable stain that fluoresces double strain 
DNA by binding to the minor grooves in the double helix.  While Hoechst dyes have a 
preferred attraction to sequences with more thymine and adenine, they will bind securely 
to all nucleotide groups [183].  The stain quantifies nuclear damage based on fluorescent 
intensity and can be measured by spectroscopy and microscopy.  Hoechst 33342 (Sigma-
Aldrich Co., St. Louis, MO) was chosen with a concentration of 16.2 mM as the stock 
solution.  The stock was diluted to 2 µg/mL in sterile water and used as the experimental 
working solution. 
After plasma fluid treatment, cells were washed with sterile 1X PBS and 
aspirated.  Serum containing media (100 µl) and the working solution (100 µl) were 
added to RAC containing wells and incubated for 30 minutes at room temperature away 
from the light.  After dye incubation time, RACs were aspirated and washed in sterile 1X 
PBS.  Cells were re-suspended in 250 µl of media and analyzed via microscopy.  Images 
were taken with the EVOS FL Color Imaging System (Life Technologies, Grand Island, 
NY) and quantified by ImageJ software. 
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5.2.6. Wound Infection Treatment with Plasma-Activated PBS Solution 
Plasma-activated PBS solution is currently under investigation as a method of 
wound disinfection.  Application of the solution to the wound site is not an acceptable 
technique, as the fluid would maintain contact for only a short period of time.  It would 
also limit the patient’s mobility as the solution needs a minimal amount of exposure time 
to be effective.  Therefore, a standard alginate wound dressing (Tegaderm HG Alginate 
Wound Dressing, 3M, St. Paul, MN) was used as a transport vehicle.  It has been reported 
by numerous groups that non-antibiotic alginate dressings do not hold any antimicrobial 
properties or wound healing accelerators [184, 185].  This ensures that any change in 
bacterial load or wound fibroses versus our control (untreated) samples could only be due 
to our plasma-activated PBS solution.  Wound infection studies were conducted in vivo 
with porcine models.  The study had two components.  First, wound tissue toxicities of 
the plasma-activated alginate wound dressings would be compared to clinically used 
chlorhexidine-containing gels.  Second, wound healing and wound decontamination 
responses will be explored following manual bacterial inoculation.  A saturated dose of S. 
aureus was used as it is a member of the normal skin flora family. 
Animals (Yorkshire swines, females) arrived at the Drexel College of Medicine 
(DUCOM) animal husbandry facilities and were given 7 days to acclimatize.  On the day 
of the surgery, one animal was transported from the vivarium to the surgical operation 
room.  Animals were anesthetized under isoflorane and laid prone on a heated water pad.  
The hair from the dorsal thorac-lumbar region was the shaved with electric clippers and 
the exposed skin thoroughly cleaned with chlorhexidine scrub solution.   After 5 minutes 
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of scrubbing, the area was washed with normal saline solution and allowed 5 minutes to 
air dry.  The process was repeated once more prior to the start of wound incisions. 
Eighteen partial-thickness wounds approximately 1 cm x 1 cm were made on the 
dorsal surface with 9 on each side (Fig. 44).  Bleeding was controlled with sterile gauze 
and manual applied pressure.  
 
 
Figure 44: Anesthetized female Yorkshire swine before and after partial-thickness wounds 
 
 
The first 6 wounds were left uninfected for wound toxicity studies.  Wounds 7-18 were 
infected with 100 µL of 107 S. aureus (ATCC, 25923) in order to determine wound 
decontamination and healing.  Inoculated wounds were allowed 30 minutes of incubation 
time in the open wound before dressing/gel placement. 
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Table 13: In vivo plasma-activated PBS on alginate wound dressing experimental conditions 
Wound Numbers Experimental 
Condition 
Infection Plasma Treatment 
1-3 Control – 
Chlorhexidine 
Gluconate Dressing 
No No 
4-6 Alginate wound 
dressing treated with 
plasma-activated PBS 
No Yes 
7-9 Control – 
Chlorhexidine 
Gluconate Dressing 
Yes No 
10-12 Alginate wound 
dressing in sterile PBS 
Yes No 
13-15 Alginate wound 
dressing treated with 
plasma-activated PBS 
Yes Yes 
16-18 Direct plasma 
treatment of calcium-
alginate gel 
Yes Yes 
 
Wounds 1-3 were covered with a standard chlorhexidine gluconate dressing (3M, 
St. Paul, MN) and Tegaderm, a flexible adhesive plastic used to fix wound bandages in 
place.  Wounds 4-6 were covered with plasma-activated PBS soaked alginate wound 
dressings.  These wounds were then held in place with Tegaderm.  The infected wounds, 
7-18, had four different experimental conditions.  Wounds 7-9 were covered with 
chlorhexidine gluconate dressing and Tegaderm.  Wounds 10-12 were covered in sterile 
untreated PBS soaked alginate wound dressings.  Wounds 13-15 were covered with 
plasma-activated PBS soaked alginate wound dressings.  Wounds 16-18 were an extra 
variable group.  Prior to animal studies, our group previously developed a custom 
calcium alginate gel that maintained antimicrobial properties following direct plasma 
treatment.  These treated gels were used as the last in vivo experimental group. 
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Following dressing and gel placement, the animal was bandaged secure to prevent 
the dressings and gel from movement but loose enough to prevent discomfort.  Six inch 
Sensiwrap (Jorgensen Labs Inc, Loveland CO) and 6 inch specialist casting padding 
(BSN Medical Inc, Hamburg, Germany) were used as a soft base layer to keep the gels 
and dressings stationary while causing little to no irritation to the pig dermis.  Six inch 
Petflex (Andover Healthcare Inc, Salisbury, MA) covered the previously layered wraps in 
order to provide more support and protection.  Finally, 3 inch Elastikon (Johnson & 
Johnson, Skillman, NJ) was applied above and below the dressing, ensuring nothing 
could travel under the previously added layers and reach the wound samples (Fig. 45). 
 
 
Figure 45: Applied gels, dressings, Tegaderm, and bandages 
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The animal was gently revived and transported back to the vivirum where it was 
put under observation for 72 hours.  Animals were checked twice daily post-operatively 
then once daily until termination.  Culture swab (CultureSwab EZ, Fisher Scientific, 
Philadelphia, PA) samples were collected and bandages, gels, and dressings were 
changed on days 1, 2, and 4 following the initial surgery.  Final culture swab samples 
were taken on day 7 along with punch biopsies (Premier Seamless Uni-Punch, Moore 
Medical, Farmington, CT) of the wounds for histopathology analysis.  During days 1, 2, 
4, and 7, the animal was placed under light isoflurane anesthesia while sampling and 
bandage exchanged occurred.  The animal was terminated on day 7.  Culture swap 
samples were serially diluted and plated on TSA (Becton, Dickinson and Company, 
Franklin Lakes, NJ) for colony counting assay analysis.   
5.3. Results 
5.3.1. Live/Dead Viability Assay 
 Images of the Live/Dead stained rat aortic cells (RACs) after plasma-activated 
PBS treatment were taken at 10x magnification (Table 12).  The reference bar at the 
bottom of each image represented a 1000 µm distance.   
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Table 14: Live/Dead images of RAC after plasma-activated PBS treatment. 
 0 minute 1 minute 5 minute 10 minutes 
D
ay
 0
 
    
D
ay
 1
 
    
D
ay
 2
 
    
 
 
 Spectrophotometry was used to quantify the green/red ratio of cells for each 
sample and condition (Fig. 46A).  These ratios were normalized versus the control 
(untreated) samples in order to determine cellular viability. 
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Figure 46: Green/Red ratio of RACs (A) after plasma-activated PBS treatment and (B) its normalized 
cellular viability versus negative (untreated) control samples with standard error 
 
 
 Based on membrane integrity, RACs showed 80% viability at 1 and 5 minutes of 
plasma-activated PBS solution at 0, 1, and 2 days post-treatment (Fig. 46B).  However, 
there was some difference of cellular integrity over observed days at the 10 minute time 
point.  On Day 0 (initial treatment of cells), we saw only 30% viability.  We previously 
demonstrated that a sub-lethal dose of plasma-activated PBS can be lethal for our E. coli 
wildtype at extended holding times.  This proved to be similar for our RACs, as there was 
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a clear decrease in cell membrane integrity at the 10 minute time point.  Interestingly, 
these cells were able to rebound 24 hours after the initial plasma dose and maintain a high 
level of cell viability 48 hours after plasma-activated PBS treatment.  RACs treated in 
vitro with plasma-activated PBS solution show no long lasting cellular membrane 
damage. 
5.3.2. Cellular Respiration Assay (XTT)  
 After confirming RAC membranes remained intact after plasma-activated PBS 
treatment, the next step was to confirm the changes of cellular respiration following 
plasma-activated PBS exposure.  XTT dye was used to detect and measure by-products of 
cellular respiration. 
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Figure 47: Cellular respiration of RACs (A) after plasma-activated PBS treatment and (B) its normalized 
cellular viability versus negative (untreated) control samples with standard error 
 
 
 Raw absorbance of the XTT assay was measured by spectrophotometry for each 
condition and time point (Fig 47A).  This data was normalized versus the control 
(untreated) condition and plotted to represent cellular viability by measured respiration 
(Fig 47B).  We noticed little to no change when RACs treated with 1 minute of plasma-
activated PBS were compared to the control group.    This was not surprising, as E. coli 
and RACs both experienced little changes in viability at the 1 minute time point.  The 
difference in respiration at 1 minute compared to 5 minutes was substantial.  Viability 
dropped from a range of 80-100% to approximately 20% for all days the cells were under 
observation.  Unlike RACs measured at Day 1 and Day 2 for membrane integrity 
changes, cells were unable to generate respiration rebound at extended times of recovery 
post plasma-PBS treatment.  The same was true at 10 minutes of plasma-activated PBS 
exposure, with cells at 1% viability. 
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5.3.3. Nucleic Acid Hoechst Stain 
 We had proven RAC membranes remained intact after plasma fluid treatment and 
rebounded in cell viability at extended plasma-treatment holding times.  However, the 
assay for cellular respiration did not report similar results.  We instead saw a substantial 
decrease in cell respiration at 5 minutes of plasma-activated PBS exposure and close to 
total inactivation at 10 minutes.  The use of Hoechst 33342, a nucleic acid dye, verified 
the integrity of double strain DNA via fluorescent microscopy. 
Images of the Hoechst stained RACs after plasma-activated PBS treatment were 
taken at 40x magnification (Table 13).  The reference bar at the bottom of each image 
represented a 200 µm distance. 
 
Table 15: Hoechst Stain 33342 and cellular DNA images of RAC before and after plasma-activated PBS 
treatment (reference bar = 200 µm) 
 0 minute 1 minute 5 minute 10 minutes 
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 Multiple images were taken for each triplicate sample of plasma treated RACs. 
The difference between untreated cells and those exposed to plasma-activated PBS were 
visually evident.  Control RACs were properly stained and depicted clearly as individual 
cells.  RACs treated with plasma PBS depicted a more uniform stain of blue across the 
field of view.  The hypothesis was that the plasma-treated PBS damaged the DNA and 
leakage through the cell caused uneven staining throughout the samples. A semi-
quantitate cell count was conducted based on stained nucleus intensity (Fig. 48). 
 
 
Figure 48: Nucleic acid staining of RACs after plasma-activated PBS treatment by Hoechst Stain 33342 
with standard error 
 
 The trend of DNA integrity was similar to the observed trend of cellular 
respiration.  We saw >175 stained cells in our control and 1 minute samples at Days 0 
and 1.  However, 5 and 10 minutes of plasma PBS treatment reduced our stained nuclei 
count to ~50 and ~20, respectively.  The reduction of intact double strand DNA was more 
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severe for all plasma samples analyzed on Day 2.   Here, there was a drop in stained 
nuclei from >250 measured in the control group, down to 70, 80, and 30 in our three 
plasma-activated PBS holding times.   
 Overall, plasma-activated PBS did not cause any major rupture or changes to the 
cell membrane, but affected cellular respiration and produced some DNA damage.  The 
same observations were made in Chapter 2; production of lipid peroxidation with 
formation of DNA oxidation in E. coli samples.  However, the detection of local toxicity 
on a monolayer of RACs did not imply systematic distress.  Thus, In vivo animal studies 
were conducted. 
5.3.4. Wound Infection Treatment with Plasma-Activated PBS Solution – Tissue 
Toxicity 
 Tissue toxicity following the 7 day in vivo experiment was analyzed by digital 
imaging and punch biopsy (Table 14).  The wounds on day 0 were identical for both the 
positive control chlorhexdine wounds and the plasma-activated PBS containing 
wounding dressings.  All wounds were cut to partial thickness, damaging both the 
epidermis and the dermis.  This is evident by the red/pink wound bed created by the 
incision.  Minor bleeding occurred, but was quickly kept under control by manual 
pressure with sterile gauze.  The wounds reacted differently to the two types of treatment 
upon day 7 examination.  The chlorhexidine gel created a large ulceration covering the 
entirety of the wound.  This is evident by the discolored (yellow) region of the exposed 
dermis.  Ulcers prevent healing and re-epithelialization while promoting infection.  The 
plasma-activated PBS containing wound dressing promoted wound healing.  Scab 
formation began at the edges of the wound, making its way inward, protecting the wound 
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from infection and initiating the healing process.  There was also evidence of tissue 
granulation which further encapsulated the injury site. 
 
Table 16: Tissue toxicity of chlorhexidine gels versus plasma-activated PBS wound dressings 
 Chlorhexidine Gel Plasma-activated PBS + 
Wound Dressing 
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 Punch biopsies were taken on day 7 and analyzed via hematoxylin and eosin stain 
histopathology by the Pathology Department at the Drexel University College of 
Medicine.  The results confirmed ulcerations and severe necrosis from the samples 
treated with chlorhexidine gels.  The epidermis has been completely destroyed while the 
dermis experienced severe inflammation.  The size of the white vacuoles (adipose tissue) 
dramatically increased as the cellular components of the dermis became deteriorated.  
The dark pink/blue streaks running through the sample represented exudates containing 
dead or non-functional cells.  Wounds covered with plasma-activated PBS wound 
dressings contained intact epidermis and dermis.  The epidermis, depicted by the thin 
layer of dark pink tissue, had minor ulceration during the 7 day experiment but has since 
healed with evidence of re-epithelialization.  The dermis showed minor inflammation 
with mature granulation tissue formation.  A summary of histological findings can be 
found in Table 15. 
 
Table 17: Tissue toxicity histological findings 
Experimental Condition H & E Staining Features Trichrome Staining 
Features 
Chlorhexidine Gel Ulceration of epidermis & 
dermis, fibrinopurulent 
exudate on sub-cut fat, 
chronic inflammation and 
necrosis extending to 
subcutaneous fat 
Minimal fibrosis 
Plasma-activated PBS + 
Wound Dressing 
Re-epithelialization & 
minimal ulceration 
overlying mature 
granulation tissues 
extending to sub-cut fat,  
detached fragments of 
fibrinopurulent exudate 
Fibrosis extending to the 
subcutaneous fat 
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5.3.5. Wound Infection Treatment with Plasma-Activated PBS Solution – Wound 
Decontamination and Healing 
 Following culture swabbing of the infected wounds on days 1, 2, 4, and 7, 
samples were serial diluted and plated to determine bacterial efficacy after long term 
exposure to the wound dressings applied with plasma-activated PBS (Fig. 49).  
Unsurprising, there was no bacterial grow at any condition on Day 0.  This is due to the 
depth of the partial thickness wounds and the lack of natural skin flora.  The positive 
control chlorhexidine gels successfully decontaminated the infected wounds for all 
sample days.  The bacterial load for the untreated PBS added to the wound dressing 
maintains an acceptable level of consistency over 7 days.  The difference between the 
concentrations never varied more than a log over the course of the experiment, ranging 
from 106 to 107 of S. aureus growing in the wounds.   
 
 
Figure 49: Wounding infection treatment with plasma-activated PBS solution with standard error 
 
0 0 0    0    0    0    0 0 1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
1.00E+08
Chlorhexidine Gel Untreated PBS +
Wound Dressing
Treated PBS +
Wound Dressing
Plasma treated
Calcium Alginate
Gel
Ba
ct
er
ia
l V
ia
bi
lit
y 
(C
FU
/m
L)
 
Infection Treatment Conditions 
Day 0
Day 1
Day 2
Day 4
Day 7
118 
 
 The plasma-activated PBS added to the wound dressing had variable results 
during the experiment.  We saw a >3 log reduction in wound infection one day after 
inoculation when compared to our untreated sample.  Days 2, 4, and 7 only showed ~1 
log difference between untreated and plasma-activated PBS used on the wound dressings.  
Direct treatment of the custom calcium alginate gel provided similar results.  Day 1 
generated a 1.5 log reduction versus the untreated wound dressings.  Day 2, 4, and 7 were 
negligible when compared to the control.   
 Similar images used in tissue toxicity analysis were captured and recorded for 
wound healing investigation (Table 16).  All day 0 images were taken after wound 
creation and prior to bacterial inoculation.  Images for days 1, 2, 4, and 7 were taken 
upon removal of all wound dressings and gels and prior to wound debridement and 
culture swabbing.  Chlorhexidine gels progressively dried the wound area, creating a 
large ulceration visually evident by the yellowish covering of the dermis.  Untreated PBS 
containing wound dressing’s quickly generated fibrous tissue (day 1, day 2) and scab 
formation (day 4, day 7).  Plasma-activated PBS containing dressings and plasma treated 
calcium alginate gels displayed minor ulceration along with fibrous tissue formation (day 
1, day 2).  Ulcer formation ceased, replaced by further fibroses and scab formation (day 
4, day 7).   
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Table 18: Wound healing effects of chlorhexidine gels versus plasma-activated PBS wound dressings 
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There was a noticeable difference between the chlorhexidine covered wounds and 
the rest of the infected samples over the course of the 7 day study.  We saw a complete 
absence of the epidermis layer and total necrosis of the dermis via histopathology.  
120 
 
Untreated PBS containing wound dressings had fully intact epidermis and dermis. 
Granulation tissue was present within the dermis, identifiable with wound healing.  There 
was no presence or history of ulcer formation during the study.  Treatment with both 
plasma-activated PBS containing wound dressings and plasma treated calcium alginate 
gels left superficial ulceration and acute inflammation.  However, there was mature 
granulation tissue and fibrosis extending into the subcutaneous fat layer, signifying 
wound healing.  A summary of histological findings can be found in Table 17 
 
Table 19: Wound contamination and healing histological findings 
Experimental Condition H & E Staining Features Trichrome Staining 
Features 
Chlorhexidine Gel Ulceration with destruction 
of epidermis & dermis. 
Fibrinopurulent exudate 
over subcutaneous fat with 
necrosis, acute & chronic 
inflammation extending to 
deep subcutaneous fat 
Minimal or no fibrosis 
Sterile Untreated PBS + 
Wound Dressings 
Squamous epithelium 
overlying superficial mature 
granulation tissue and 
fibrosis extending to the 
subcutaneous fat.  No ulcer 
is identified. 
 
Fibrosis extending to 
subcutaneous fat 
Plasma-activated PBS + 
Wound Dressing 
Superficial ulceration with 
acute inflammation at the 
surface & dermis. Mature 
granulation tissue and 
fibrosis extending to 
subcutaneous fat 
Fibrosis extending to 
the subcutaneous fat 
Plasma Treated Calcium 
Alginate Gel 
Superficial ulceration with 
minimal acute 
inflammation. Mature 
granulation tissue and 
fibrosis extending to 
subcutaneous fat 
Fibrosis extending to 
the subcutaneous fat 
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5.4. Discussion 
 In cytotoxicity experiments, we noticed that RACs maintained membrane 
integrity at all three exposure times with plasma-activated PBS but generated decreased 
respiration and DNA degradation as holding time increased.  Similar results were shown 
with bacterial efficacy studies in Chapter 2 with slight changes in membrane integrity 
potential that ultimately lead to DNA fragmentation and bacterial death.  Previous 
cytotoxicity studies were done by Erçan et al, using plasma-activated N-acetyl cysteine 
re-suspended in PBS [186].  Here, they concluded that 3 minutes of treated solution 
caused cell death after 5 minutes of holding time.  However, when treatment time was 
reduced to < 2 minutes, they could hold cells for up to 30 minutes in solution with 
minimal cytotoxicity.  The endothelial cells (EA.hy 926) were able to rebound to nearly 
100% viability after 48 hours of recovery.  Our small volume sub-lethal plasma activated 
PBS did not demonstrate the same rebound effect, as cells held for 5 and 10 minutes with 
solution showed low levels of respiration and DNA damage via DAPI staining (Figs. 47 
& 48) even after a 48 hour recovery period..  This might be the result of the low amount 
of cells exposed to the full plasma-treated PBS dose.  Efficacy studies were carried out at 
a bacterial concentration of 107 CFU/mL while RACs were seeded at 104 and grown to 
90% confluence.  The single monolayer of RACs could have been too sensitive to the 
amount of oxidative stress provided by the plasma-activated PBS.  There was also a 
difference in the treatment volume and total applied energy between the work done by 
Erçan et al and the current solution under investigation.  The other group treated 10X the 
amount of fluid at one time while applying half the total energy (~45 J vs 88.5 J).  This 
would explain why a rebound effect wasn’t encountered when similar holding and 
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rebounded times were explored in comparison.  The use of more robust endothelial cells 
versus the sensitive aortic cells would also explain the discrepancies between the two 
cytotoxicity experiments. 
 In vivo studies comprised of three parts:  tissue toxicity, wound decontamination, 
and wound healing.  Chlorhexidine gels were cytotoxic to the partial-thickness wounds 
over the 7 day experiment.  Severe necrosis and ulcerations were the result of 
chlorhexidine tissue toxicity samples.  However, these gels were also able to achieve full 
bacterial inactivation during the wound decontamination portion of the study.  Boyce et 
al studied the cytotoxicity-antimicrobial properties of several decontaminants and 
antibiotics when exposed to keratinocytes, fibroblastas, and common burn wound 
organisms.  They reported that as little as 0.05% chlorhexidine gluconate was uniformly 
toxic to both human cells and microorganisms [187].  Goldschmidt et al discovered that 
0.1% and 0.02% chlorhexidine impaired the healing of sutured skin wounds [188].  
Another group studied the cytotoxic mechanisms behind chlorhexidine necrosis in 
fibroblasts.  They concluded that the buildup of damaged proteins in the endoplasmic 
reticulum (ER) was enough to stress and overload the ER to the point of cell death [189].  
However, the use of chlorhexidine as a topical antiseptic is a hospital standard.  
Chlorhexidine treatment of skin before blood sample collection greatly reduced surface 
bacteria concentrations and lowered the risk of infection during skin puncturing [190].   It 
has also been used as skin cleanser for newborns, reducing the mortality rate of neonates 
in developing countries [191].  Based on the finds of the current study as well as those 
previously reported, chlorhexidine makes for excellent skin antiseptics, but should not be 
in contact with more sensitive areas and open wounds. 
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 Plasma-activated PBS containing wound dressings generated very little tissue 
toxicity.  There was evidence of minor ulcer formation, but had dissipated by the day 7 
histologies.  Interestingly, the epidermis had some minor inflammation and damage 
which would confirm our previous monolayer in vitro results.  The more complex in vivo 
model was able to handle the plasma-activated PBS; display wound sterilization while 
limiting tissue toxicity.  However, these novel wound dressings were only able to 
generate >3 log bacterial reduction and not full decontamination of the initial 107 
inoculums.  One such reason might be due to the complex partial thickness wound 
environment.  Bacteria could hide in different areas and crevices generated by the 
creation of a non-uniform wound.  Organics, such as blood and wound exudates, can 
reduce the effectiveness of plasma-activated PBS [186].  Since there is a limited pool of 
ROS in each plasma-PBS sample, the biological environment of the wound consumes the 
applied plasma products before it can successfully inactivate the bacterial infection.  Any 
surviving bacteria could then proliferate within the contained wound.  The intrinsic 
response of the injury would lead to the release of leukocytes, increased capillary 
permeability, and vasodilation.  There would also be an immune response due to the 
applied bacteria.  However, at such a high dose of bacteria (107) the immune response 
could become overwhelmed.  The progression from wound colonization to infection can 
depend on the initial bacterial concentration and the potential of biofilm formed 
communities that can protect themselves from the host’s defenses [192]. 
The dressing, covering, and bandaging of the wound could also produce an 
optimal environment for bacterial proliferation.  One study created superficial wounds on 
Yorkshire pigs and infected these wounds with gram negative pathogens.  The wounds 
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were treated with either a semi-occlusive film dressing or left exposed to air.  The 
wounds covered with the film dressing saw an increase in bacterial proliferation over 
time when compared to the open air wounds [193].  
Plasma-activated PBS containing wound dressings produced negligible tissue 
toxicity while reducing the level of wound infection by > 103 CFU/mL after one day.  
However, the inability to achieve complete decontamination led to a rebound in bacterial 
proliferation.    While the technology is promising, further in vitro and in vivo studies are 
needed to optimize the volume, treatment time, and deliver mechanism involved in 
creating the plasma-activated PBS containing wound dressings.  The optimum 
components would result in a dressing that is able to fully decontaminate infected 
wounds while generating minimal tissue toxicity and stimulating wound healing factors.   
  
125 
 
6. CHAPTER VI:  CONCLUDING REMARKS 
 
6.1. Summary of Research 
The present study investigated bacterial and cellular response to non-thermal 
plasma-activated PBS solution.  The motivation driving this research can be explained in 
two parts:  development of a more effective and potent topical antiseptic and 
understanding of the method of bacterial inactivation.  Current antiseptics are unable to 
achieve full decontamination when used on living tissue.  Stronger antiseptics, which 
inactivate 99.99% of topical bacteria, can cause minor skin damage and irritation.  
Therefore, development of a broad-spectrum, non-toxic novel antimicrobial agent was 
explored. 
In Chapter two, we optimized the treatment and holding time of our plasma-
activated solution in order to study the mechanism of inactivation.  Oxidative stress 
scavengers were used to protect and rescue the bacteria to determine the role of specific 
ROS in efficacy studies.  Here, external catalase was able to increase bacterial viability 
after prolonged holding times with the plasma-activated solution.  At the same time 
oxidative stress defense gene deficient bacterial mutants were utilized.  E. coli strains 
deficient in kat were more susceptible to the plasma-activated PBS than those deficient in 
sod.   From this we conclude that hydrogen peroxide formation in this novel solution was 
the main inactivating reagent.  Physical effects, including membrane potential change, 
lipid peroxidation, and DNA fragmentation and oxidative damage, were explored.   
Bacterial exposed to plasma-activated PBS became slightly depolarized with minor 
detection of lipid peroxidation.  However, DNA degradation was evident in all wildtype 
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and deficient strains.  Bacterial protected with catalase prior to plasma-activated solution 
treatment saw little to no oxidative DNA stress or fragmentation, confirming the role of 
hydrogen peroxide in decontamination. 
 Chapter 3 utilized molecular techniques to study the transcription genes that 
regulated the oxidative changes when bacteria were exposed to plasma-activated PBS.  
Microarray analysis was used as a tool for global gene expression.  Regulons oxyS and 
soxS, while transcription genes katG and sodA, were all significantly up-regulated.  Other 
genes involved in oxidative defense, such as ahpF, ahpC (alkyl hydroperoxide 
reductase), grxA (glutaredoxin), recN and recD (DNA repair), were also highly 
expressed.  Specific primers for oxidative defense genes were created for quantitative 
PCR experiments.  OxyS and katG were consistently up-regulated for all strains exposed 
to the plasma-activated solution.  SoxS and sodA were also up-regulated; however, 
expression was dependent on the presence or deletion of other defense genes.   While we 
hypothesized that hydrogen peroxide was the primary inactivation reagent, superoxide 
and nitric acid are still generating a measureable response. 
 Chapter 4 provided analysis of the plasma-activated PBS composition.  Singlet 
oxygen, superoxide, and peroxides were detected via EPR analysis using spin traps 
DMPO and CPH-O.  Specific scavengers were added to the solution to determine the 
presence of superoxide while verifying the generation of singlet oxygen and peroxide by 
direct plasma treatment of buffer and not by secondary chemical reactions.  By using 
manganese oxide as a standard, we calculated 2.03·10-4 M of singlet oxygen and 5.40·10-4 
M of peroxide in plasma-activated PBS.  UV-Vis spectroscopy measured the composition 
of the solution over extended periods of storage time.  A prominent peak at 302 nm, 
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concluded as nitric acid, remain constant in all samples held for 6 months.  There was 
6.00 mM of HNO3 in our sub-lethal plasma dose.  Nitric acid remains stable in low pH 
environments.  Sub-lethal plasma-treated PBS has a pH of ~2.  Buffer treated with 
plasma for small durations (5-25seconds) gave rise to multiple peaks in the 340-380 nm 
range.  This has been attributed to both nitric oxide and nitrous acid.  NO2 is initially 
formed in the solution.  As treatment time continues and pH drops, the NO2 converts to 
HNO2.  This phenomenon was only witness immediately following treatment, as samples 
retested 24 hours later only displayed a peak at 302 nm (HNO3).  The assumption is that 
plasma generated ROS further oxidizes the unstable HNO2 into the more stable HNO3. 
 Chapter 5 explored cytotoxicity in vitro and in vivo.  Rat aortic cells (RACs) were 
exposed to plasma-activated PBS and measured for membrane integrity, cellular 
respiration, and nucleic acid staining 0, 24, and 48 hours after exposure.  Cell membranes 
remained intact following treatment, however, respiration rates declined and DNA 
integrity diminished as plasma-activated solution holding times increased.  Even with a 
24 and 48 hour time period to rebound in viability the cells were unable to revive.  
Monolayer cellular toxicity did not imply in vivo toxicity in a more complex biological 
environment.  Therefore, tissue toxicity and wound infection studies were conducted on a 
porcine model.  Plasma-activated PBS containing dressings generated little systemic 
toxicity and stimulated re-epithelialization in the epidermis and dermis of partial-
thickness wounds.  The dressings were also able to disinfect > 3 logs in wounds infected 
with an initial inoculum of 107.  However, this number decreased over the span of the 
study, as safety precautions used to protect the wounds from outside infection only 
generated optimal breeding environments for bacterial proliferation.  Nonetheless 
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plasma-activated PBS containing dressings are a safer alternative to chlorhexidine gels in 
terms of tissue toxicity and cellular damage. 
6.2. Future Work 
 Antibiotic resistant bacteria steadily have risen since the advent of antibiotics in 
medicine.  Creation of a novel antimicrobial such as plasma-activated PBS was partially 
inspired as a potential antibiotic alternative.  However, it is to be expected that constant 
usage of plasma-activated solution would eventually give rise to antibacterial potency 
reduction over time.  The best way to study the evolution in bacterial defense against this 
novel antimicrobial would be treatment by sub-lethal dose.  New cultures could then be 
grown from the surviving bacteria, creating a passage of the strain.  The new passage 
would once again be subjected to a sub-lethal dose of plasma-activated PBS.  This would 
be continued for multiple passages, allowing the bacteria to build a tolerance to the 
solution.  After a set number of passages (~20), the applied plasma dose would be 
gradually increased.  This would prevent the bacteria from reach a defensive “plateau” 
against the antimicrobial agent.  Analysis could be carried out by colony counting and 
gene expression every 20 passages.  Upon the last passage, the initial sub-lethal dose 
would be re-administered and comparisons between the initial passage and final passage 
would provide evidence or absence of resistance.  It is in the author’s opinion that while 
plasma-resistance remains a possibility, it would take much longer to develop than 
antibiotic resistance.  We have demonstrated that plasma inactivates bacteria through 
several oxidizing reagents and biological pathways.  Generating resistance to each would 
take a considerable amount of adaptation.  Treatment of PBS with non-thermal plasma 
also offers many adjustables in comparison to antibiotics.  By changing the applied 
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energy (voltage, current, treatment time), fluid volume, electrode geometry, or pulse 
duration (microsecond and nanosecond) one can essentially create a new product with 
different concentrations of ROS and RNS. 
 While the wound dressings used to transfer the plasma-activated PBS properties 
to the porcine model generated little tissue toxicity and demonstrated 3 logs of 
disinfection, a more suitable delivery system needs to be explored.  The development of a 
plasma treated calcium alginate gel seems promising, but requires direct treatment and is 
not suitable as a fluid transfer vehicle.  The gels could be stored in plasma-activated 
buffer after direct treatment and prior to use.  This may increase the bactericidal effects.  
Further investigation is required.  Changing the type of buffer treated by non-thermal 
plasma is another avenue of exploration.  Different concentrations of buffer ingredients 
may have an effect on the amount of ROS formation as well as stability rates.  A 
comparative study of various buffers treated by non-thermal plasma and its antimicrobial 
effect should be considered. 
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